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Recent advances in understanding lung biology have shown evidence for the existence of 
resident lung stem cells. Independent studies in identifying and characterizing these somatic lung 
stem cells have shown the potential role of these cells in lung repair and regeneration. While 
identifying a homogenous stem cell pool with unique cell surface markers is still a challenge, the 
currently available data support the existence of different lung cells with stem cell characteristics 
of self-renewal and differentiation. Understanding the functional characteristics of these tissue 
resident stem/progenitor cells has gained much importance with increasing evidence of cancer 
stem cells, cells in a tumor tissue with stem cell characteristics. Lung cancer is most commonly 
characterized by loss of p53 function which results in uncontrolled cell divisions. Incidence of 
p53 point mutations is highest in lung cancer, with a high percentage of missense mutations as a 
result of tobacco smoking. Certain point mutations in p53 gene results in its oncogenic gain of 
functions (GOF), with enhanced tumorigenic characteristics beyond the loss of p53 function. 
However, there are no available data on characterization of lung stem cells carrying GOF 
mutations and correlating them with those of normal stem cells, in this study, for the first time 
we show that percentage of Sca-1 expressing subpopulation is significantly higher in the lungs of 
mice carrying p53 GOF mutations than those in lungs isolated from p53+/+ wild type mice. 
Additionally, our results show that Sca-1High subpopulations isolated from p53 GOF mutant 
knock-in mice possess distinct mesenchymal morphology, higher proliferation and limited 
differentiation potential compared to their wild type counterparts. Further, we noted difference in 
self-renewal ability, tumorigenic potential, and differentiation ability within the putative lung 
stem/progenitor cells isolated from two different p53 GOF mutant knock-in mice.  
  
 
 
In the second part of our study, we investigated the role of PDGFR-α as a potential stem cell 
marker. We successfully established lung cells differentially expressing two cell surface markers, 
Sca-1 and PDGFR-α, with results demonstrating existence of different subpopulations of cells in 
the lung. We noted that cells expressing Sca-1Low and PDGFR-α High show no differentiation 
capability, suggesting that these cells lack stem cell characteristics. While all other sorted 
subpopulations exhibited differentiation potential, Sca-1High/PDGFR-αLow and Sca-1High/PDGFR-
αHigh subpopulations show more robust differentiation ability and higher proliferation 
respectively. These results suggest that incorporation of PDGFR-α as an additional cell surface 
marker along with Sca-1 enables us to further identify specific subpopulations with defined stem 
cell characteristics. Overall, our findings aide to increase the understanding of lung cell biology, 
highlights the need of additional surface markers to identify and isolate more homogenous 
stem/progenitor cells, and furthers our understanding of stem cells in the context of lung cancer. 
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CHAPTER 1:  LITERATURE REVIEW 
 
 
 
 
1.1 Adult stem cells 
There has been emerging evidence of presence and prospective isolation of somatic stem cells in 
various tissues and organs. (Kim et al., 2005; Sherwood et al., 2004; Stingl et al., 2006; Uchida 
et al., 2000). Of all the somatic stem cells studied in mouse and humans, the blood forming 
hematopoietic stem cells (HSC) were one of the first to be purified and characterized in the 
mouse (Spangrude et al., 1988). HSCs have been extensively studied in detail with in vitro and in 
vivo studies resulting in invaluable amount of data about their functions and successful clinical 
applications (Bryder et al., 2006). The lineage hierarchy of HSCs, from a self-renewing stem cell 
to lineage restricted cells, has been well-defined and well-characterized than any other tissue 
specific stem cell (Graf, 2002; Weissman et al., 2001)(Figure 1-1). Each cell type in this 
hierarchy has been identified with specific or combinations of cell surface markers that define 
their phenotype. The HSC reside at the top of the hierarchy and are characterized to be a side 
population of cells with higher self-renewal; and multipotent differentiation capability to 
generate specialized cells with specific functions. They give rise to multipotent and oligopotent 
progenitor cells, characterized by limited self-renewal but, higher proliferation ability. Unlike
 1 
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 HSC, the multipotent and oligopotent progenitor cells possess limited differentiation capability, 
which can form 2 or more mature cells within the tissue they reside in. Oligopotent progenitors 
constitute common myeloid, lymphoid and other progenitor cells that give rise to mature effector 
cells such as erythrocytes, platelets-cells, T-cells, B-cells and other mature blood cells which  
exhibit no self-renewal (except memory T and B cell) and limited proliferation. A 
comprehensive knowledge on characteristics of each cell type in the HSC lineage hierarchy, 
research on their gene expression profiles and mouse transplantation studies has enabled progress 
the use of HSCs in clinical applications to treat leukemia blood cancer and other autoimmune 
blood cell diseases (Weissman, 2000b; Weissman and Shizuru, 2008; Wilson and Trumpp, 
2006). With evidence of somatic stem cells in other tissues, it is important to gain in-depth 
understanding of these resident stem cells. 
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Figure 1-1: Schematic representation of adult stem cell self-renewal 
Asymmetric self-renewal properties of somatic stem cells results in a stem cell and a progenitor 
cell. The progenitor cells divides repeatedly and give rise to post-mitotic terminally 
differentiated cells, thus maintaining homeostasis and stem cell pool of a tissue. 
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The human body is comprised of about 200 different types of cells with specialized functions 
that are unique to the specific tissue or organ in the body. Over the lifetime of a human being, 
these cells are replenished as a result of cell death or injury to maintain cell homeostasis in the 
body. This is attained by the resident stem cells in response to a stimuli, which by self-renewing 
maintains respective stem cell pool of the specific tissue or organ (Slack, 2000; Weissman, 
2000a).  Few in vivo studies in hematopoietic system suggest development plasticity of these 
adult stem cells, an ability to generate differentiated cells beyond their own tissue boundaries 
(Korbling and Estrov, 2003). This versatility of somatic stem cells with potential plasticity is 
considered a rare phenomenon, which need better understanding and yet to be established across 
different tissues (Wagers and Weissman, 2004).  
 
The cell divisions that are most commonly noted in human body are symmetrical, where two 
identical daughter cells are formed from a parent cell. This phenomenon is also noted in different 
types of cells (e.g., skin cells, lung cells, fat cells, neural cells) that are grown in vitro. However, 
these lineage committed primary cells have a limited division capability, which are eventually 
replenished by differentiation of respective somatic stem cells. In order to maintain long-term 
cell homeostasis during the life time of a human being, it is required that the stem cell pool is 
preserved while meeting the specific requirements in a tissue. With the current understanding of 
stem cell biology, researchers have noted that this exquisite balance between self-renewal and 
differentiation could be achieved by only asymmetric division and are believed to be regulated in 
the stem cell niche of the respective tissue (Watt and Hogan, 2000).  Two self-renewal strategies 
are proposed for these somatic stem cells, population asymmetry and single cell asymmetric 
division(Figure 1-2) (Morrison and Kimble, 2006; Shen et al., 2004). In population asymmetry, 
 4 
Back To Table of Contents 
the balance between self-renewal and differentiation is attained at the population level, where 
some stem cells differentiate resulting in progenitor cells that eventually proliferate to form 
specialized cells, while other stem cells go through symmetric self-renewal to maintain stem cell 
numbers in the pool. In singe cell asymmetry, the somatic stem cell divides asymmetrically into 
a stem cell and a progenitor cell, thus maintaining a constant stem cell pool in the respective 
tissue (Klein and Simons, 2011; Simons and Clevers, 2011). It is still unclear if this asymmetry 
is regulated by internal (asymmetric segregation of fate determinants during cell division) or 
external (stem cell niche) factors. Since, cell division is a complex internal process involving 
DNA replication and segregation it is important to maintain high fidelity with no chance for 
errors (Fuchs et al., 2004; Ho, 2005). Hence, somatic stem cells are considered to be slow-
cycling cells and asymmetric division at single cell level supports this view. On the other hand, 
lineage tracking studies and development of inducible genetic systems has allowed investigating 
population asymmetry in some tissues (e.g., intestinal crypt), with results suggesting that self-
renewal of stem cells follows a stochastic pattern where alongside with single cell asymmetric 
division, population asymmetry also exists to maintain tissue homeostasis and stem cell pool 
(Shahriyari and Komarova, 2013). However, in-depth understanding of somatic stem cell 
division is still an area of active research which requires development of different cellular assays 
to monitor cell division both in vitro and in vivo. 
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Figure 1-2: Schematic representation of two possible somatic stem cell divisions. 
Population asymmetry (A) is characterized by differentiation of a stem cell into progenitor cell, 
where the loss of stem cell is replenished by a symmetric division of a stem cell in that niche. On 
the other hand, Single cell asymmetry (B) is characterized by division of stem cell into two 
different cells, a progenitor cell and a stem cell. 
  
 6 
Back To Table of Contents 
The evidence for existence of somatic stem cells has increased over years. Our body is 
comprised of various tissues and organs that demonstrate regenerative potential at respective 
levels. Some tissues (blood, skin, gut, respiratory tract) are extensively exposed to harsh 
environments and hence perpetually replenish damaged cells. While some tissues are poorly 
regenerative (e.g., heart, lung) and others are highly regenerative (e.g. liver), various studies have 
reported resident stem cells with self-renewal and multipotent capability in different tissue types 
(Wagers and Weissman, 2004). These adult stem cells were identified based on expression of 
different cell surface markers, some of these markers that have been commonly used are listed ( 
Table 1.1-1) These differences in regenerative potential are yet to be understood at the cellular 
level, but their classification based on potency and tissues of origin provide some insights. The 
stem cells are majorly classified based on their differentiation potential, as pluripotent (ability to 
generate all body cells, including germ cells e.g. ESC), multipotent (ability to generate all tissue 
cells, e.g. HSC), unipotent (ability to generate only single cell type; e.g.: spermatogonial stem 
cells). Depending on their tissue of origin/location,  differentiation potential, these somatic stem 
cells are broadly classified as, epithelial stem cells (e.g. intestinal lining, skin), mesenchymal 
stem cells (e.g., bone marrow), hepatic stem cells (liver). However, certain organs like the lung 
contain both epithelial and mesenchymal stem cells. In order to understand self-renewal and 
differentiation potential of different stem cells, identification and isolation of these cells from 
their respective tissue is an important necessity. Even though different research studies have 
identified different cell surface markers that correlate with stem cells of respective tissues, these 
are not very specific or exclusive for stem cells alone. Some of the cell surface markers that are 
employed to identify these specific stem cells are listed in Table 1.1-1 below. There is need for 
improved isolation techniques, cell culture protocols and detailed molecular analysis to identify 
 7 
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stem cells with distinct characteristic of self-renewal and differentiation (Barker et al., 2010; 
JM., 2000; Ute Bissels, 2013). 
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Cell surface markers 
studied 
Tissue/ Organ resident 
somatic stem cells reported 
References 
Bone morphogenetic protein 
receptor (BMPR) 
CD34+Sca1+Lin- profile 
 c-Kit Hoechst dye 
Bone marrow 
(Morikawa et al., 2009; 
Wilson and Trumpp, 2006; 
Zhau et al., 2011) 
Sca-1, c-Kit, CD34 Lung  (Raiser and Kim, 2009) 
Leucine-Rich G Protein-
Coupled Receptor 5 (LGR5), 
BMI-1,  
Intestine 
(Barker et al., 2010; Korbling 
and Estrov, 2003; Morrison 
and Kimble, 2006; Wagers 
and Weissman, 2004) 
Galectin-1, CD133 Neural stem cells (Shen et al., 2004) 
Integrin α6, CD 34 Epidermal stem cells (Barker et al., 2010) 
Table 1.1-1: Commonly studied cell surface markers in identification and isolation of adult 
stem cells. 
Somatic/adult stem have been studied in a variety of organs and tissues such as bone marrow, 
brain, lung, and other epithelial tissues. The table summarized the commonly used cell surface 
markers to identify, isolate and establish self-renewing adult stem cells across these different 
tissues and organs.  
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1.2 Stem cells in the lung 
The lung is considered to be a highly heterogeneous organ with a variety of cells located in 
distinct regions of the organ. Functionally distinct putative stem cells were shown to reside in 
different anatomical regions of the respiratory system, which play a key role in repopulating the 
cells in their local area (Alamgeer et al., 2013; Hegab et al., 2010; Kajstura et al., 2011; Kim et 
al., 2005; Singh et al., 2012). Studies have reviewed the role played by the local stem cells found 
in trachea (basal, mucous secretory), bronchus (basal, mucous secretory), bronchiole (clara), and 
alveolus (type II pneumocyte) and have shown that they primarily contribute to regeneration of 
lost cells/tissues in response to injury (Otto, 2002). 
 
Identification of resident multipotent lung stem cells that can differentiate into any lung cell is 
still an area of active research. Two major types of stem cells, namely epithelial and 
mesenchymal stem cells have been reported in the lung so far (Hegab et al., 2010; Kim et al., 
2005; Summer et al., 2007). These cells were isolated and characterized based on specific cell 
surface markers that are unique to certain cell lineages. In line with the heterogeneous nature of 
the lung, the cells that reside in different regions of the lung exhibit differential expression of 
various cell surface markers. A classic stem cell marker used in the identification of 
hematopoietic stem cells, Stem cell antigen (Sca-1), has also been found to be expressed in some 
cells of mesenchymal origin (Holmes and Stanford, 2007). Studies have demonstrated that lung 
cells expressing Sca-1 were predominantly found in distal regions of lungs and were shown to 
possess a temporal emergence, indicated by enrichment of Sca-1 expressing cells in adult mouse 
lungs when compared to neonatal lungs. Sca-1pos cells have been shown to emerge in postnatal 
lung during the branching of the airways/lung vasculature and increase exponentially in adult 
 10 
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lungs (McQualter et al., 2009). Based on the expression of Sca-1 and other markers, various 
studies have identified unique subpopulations in lung that possess stem cell characteristics 
(Raiser and Kim, 2009) . Thus Sca-1 emerged as a representative cell surface marker to identify 
the lung stem cells. 
 
Bronchioalveolar stem cells (BASCs) isolated, from bronchioalveolar duct junction in adult 
mouse lungs, based on expression of Sca-1 and CD34 (Hematopoietic and epithelial markers) 
were shown to exhibit self-renewal and multipotent capabilities. In in vivo studies, the BASCs 
were shown to participate in lung epithelial cell renewal and maintain bronchiolar, clara and 
alveolar cell populations in the distal lung (Kim et al., 2005). Gene expression analysis on Sca-
1neg, CD45neg, CD31neg lung populations and corresponding Sca-1pos cell lines were shown to 
possess epithelial and mesenchymal gene expression profiles respectively, signifying the 
presence of Sca-1pos cells with mesenchymal characteristics (McQualter et al., 2009) (Hegab et 
al., 2010). Moreover, the Sca-1pos, CD45neg, CD31neg were enriched with mesenchymal 
progenitor cells in culture as shown by their spindle shaped morphology and expression of 
mesenchymal markers (CD104a, Vimentin). In contrast, Sca-1neg, CD45neg, CD31neg cells were 
shown to possess cobblestone epithelial cell morphology and epithelial marker expression (E-
cadherin, cytokeratins 5 and 14, and proSP-C) (McQualter et al., 2009). From a functional 
standpoint, the isolated and characterized stem cells in the lung are believed to play an important 
role in maintaining lung homeostasis. Bronchiolar stem cells have been functionally defined by 
their expression of clara cell secretory protein (CCSP), pro-surfactant protein C and were shown 
to reside in airway epithelium (Giangreco et al., 2002; Hong et al., 2001). A systematic study 
conducted by Teisanu et al has identified bronchiolar stem cells phenotype as  CD45neg, CD31neg, 
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CD34neg, Sca-lLow AFLow  (Teisanu et al., 2009) as opposed to Sca-1pos, CD34pos , , CD45neg, 
CD31neg reported earlier by (Kim et al., 2005). Based on studies with transgenic mice models 
associated with stem cell expansion, ablation, and lineage tracing, Teisanu and colleagues  
demonstrated that CD34pos populations do not belong to the airway epithelium, while CCSP 
expressing cells are found in CD34neg, Sca-lLow and  AFLow populations (Teisanu et al., 2009).  It 
is useful to note that evidence of different subpopulations  in lung cells with potential stem cell 
properties has been attributed to the method of isolation, culturing conditions, and choice of 
markers (Raiser and Kim, 2009). These studies indicate the complex nature of lung and presence 
of one or more putative stem cells in the Sca-1pos CD45neg CD31neg pool. Details of isolation and 
characterization of these cells have been detailed in recent articles published by our group and 
others (Gadepalli et al., 2013; Hegab et al., 2010). 
  
In humans, lung stem cells with self-renewing, clonogenic, and multipotent (in vitro and in vivo) 
properties were shown to exist. These were identified and isolated based on expression of c-kit in 
combination with other cell surface markers (Kajstura et al., 2011). The c-kitpos cells were 
negative for hematopoietic and mesenchymal markers and interestingly demonstrated positive 
expression of key markers associated with pluripotency: OCT4, NANOG, KLF4, and SOX2. 
However, a key defining feature of somatic stem cells that differentiates them from pluripotent 
stem cells is that they undergo asymmetric division that results in the generation of a 
heterogeneous population of stem cells and progenitor cells. This study has been received with 
some skepticism putting forward several questions and need for independent studies to ascertain 
existence of somatic lung stem cells in humans (Stripp BR, 2011).  
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The fact that lung tissue is composed of a variety of cells with distinct phenotypes and functions 
complicates our understanding of lung regeneration.  This is evident from multiple research 
studies where lung cells characterized by different markers were shown to possess core stem cell 
properties of self-renewal, clonality, and multipotent characteristics (Hegab et al., 2010; Kim et 
al., 2005; Raiser and Kim, 2009). While these research studies promise a step ahead in 
identifying putative lung stem cells, there are challenges that need to be addressed. One such 
challenge is to define a unique set of cells that possess multipotent capability as well as play a 
crucial role in lung regeneration. This is not only expected to strengthen our attempts to develop 
focused therapeutic strategies in the context of wound healing but also in identifying and 
targeting putative cancer stem cells in the lung. Some of the studies carried out in identifying 
lung stem cells in mouse and their characteristic features described by experimental evidence are 
summarized in Table 1.2-1. 
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Markers for sorting 
Anatomical location 
of cells 
Comments Reference 
Sca1pos, CD34pos, 
CD45neg, CD31neg 
Bronchi alveolar duct 
junction 
These cells were 
positive for clara cell 
marker and Surfactant 
protein marker. 
(Kim et al., 2005) 
Sca1pos, CD44pos, 
CD106pos, CD45neg, 
CD31neg 
Sca1 expression is 
predominantly found 
in Distal Lung, 
restricted to 
Endothelial and 
Perivascular Cells 
Similar to other 
mesenchymal 
progenitors, these 
cells express Sca-1, 
CD106, CD140a 
(PDFGR-a) and 
CD44. 
(Holmes and 
Stanford, 2007) 
Sca1pos, CD45neg, 
CD31neg 
- 
Differentiated into 
endothelial and lung 
epithelial (alveolar 
type I, II, and clara) 
(Hegab et al., 2010) 
Table 1.2-1: Cell surface markers studied to identify adult lung stem cells. 
The above table summarizes cell surface markers employed across different research studies to 
identify and isolate somatic/ adult stem cells in the lung. It also highlights the anatomical 
location and specific characteristics of lung subpopulations that these studies have established by 
using a combination of different cell surface markers. 
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1.3 Lung cancer 
One of the leading causes of cancer-related deaths is cancer of the lung, of which 80-90% is 
attributed to tobacco smoking (Ferlay J, 2013; Jemal et al., 2011). More than 50 different 
histological variants of lung cancer have been recognized by the World Health Organization 
(WHO) and classified based on their phenotype, their zone of origin in the lung, or by tumors 
arising from functionally diverse lung cells (Travis, 2004). This diversity characterizes the 
neoplasms in lung as heterogeneous with different histological subtypes. Almost 98% of lung 
cancers are carcinomas (tumors arising from epithelial cells) and based on the size of a cancer 
cell, categorized as small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) 
carcinomas. SCLCs and NSCLCs constitute approximately 10-15 % and 85-90% of lung cancers 
respectively (Travis, 2002, 2011). The SCLCs are malignant small epithelial cells with scanty 
cytoplasm. The NSCLCs are further classified based on their size and shape as large cell 
carcinoma, squamous carcinoma, and adenocarcinoma. NSCLCs are relatively larger in size and 
contain a high nucleus to cytoplasmic ratio (Travis, 2002; Travis, 2004; Travis et al., 1995). 
Additionally, other rare subtypes of lung cancer include bronchioalveolar carcinoma, carcinoid, 
glandular, and neuroendocrine tumors. 
  
According to NCI PDQ®, of all the subtypes in lung cancer, the incidence of squamous and 
adenocarcinoma are considered to be the highest (NCI, 2014). Studies comparing the major four 
subtypes of lung cancer recognized that the rate of development of adenocarcinoma is more 
common and constitute approximately 40% of these lung cancer subtypes in humans, with the 
cause strongly associated with tobacco smoking (Kenfield et al., 2008; NCI, 2014; Travis, 2004). 
Various other factors such as asbestos, arsenic, radon (radioactive gas formed as a result of 
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breakdown of uranium in soil), and environmental air pollution also pose a risk of lung cancer 
(Subramanian and Govindan, 2007). Epidemiological studies and molecular biology studies have 
indicated a high risk of at least 20 carcinogens in tobacco smoke that can cause lung cancer 
(Hecht, 1999). Research has shown that tobacco carcinogens such as polycyclic aromatic 
hydrocarbons (benzo[a]pyren) target hot spots in codon regions of TP53 by forming DNA 
adduct, thus forming sites for mutations in cancer (reviewed and summarized in (Toyooka et al., 
2003)).  The systematic analysis based on different lung cancer research data uploaded at 
International Agency for Research on Cancer (IARC) indicates a moderate relationship between 
smoking exposure and mutation pattern in codon regions (157, 158, 175, 245, 248, 249 and 273) 
of TP53, suggesting that mutational pattern in cancers arising in smokers is not specific to a 
single codon. Studies also confirmed a high frequency in G: C to T: A transversions in TP53 
coding region of smokers (16%) than in non-smokers (5.8%). One key observation in their 
analysis is change of mutational spectrum based on gender. For instance, G: C to T: A 
transversions found to be higher in female smokers (36%) than male smokers (27%) (Ezzati et 
al., 2005; Toyooka et al., 2003). The advances at molecular level in understanding the cause of 
cancer and research studies targeting identification of cancer stem cells hold promise for 
development of novel approaches in diagnosis and treatment of lung cancer.  
 
1.4 Cancer stem cells in the lung  
Over the past few decades, advances in cancer research have enabled us to understand the 
different mechanisms that contribute to the aberrant proliferation of normal cells into abnormal 
cells that result in tumors.  In the pursuit to find cures, researchers have primarily focused on 
various molecular level changes that are unique to cancerous cells.  In humans, about 50% or 
 16 
Back To Table of Contents 
more cancers have a mutated tumor suppressor p53 gene thereby resulting in accumulation of 
p53 protein and losing its function to activate the target genes that regulate cell cycle and 
apoptosis. Extensive research conducted in murine cancer models with activated p53, loss of 
p53, or p53 missense mutations has facilitated researchers to understand the role of this key 
protein. In spite of identification of numerous triggers that cause cancer, specific cures still 
remain elusive. One of the primary reasons attributed to this is due to the fact that the tumor 
tissue is heterogeneous and contains numerous subpopulations of cells. Studies have shown that 
a specific subpopulation of cells termed as cancer stem cells (CSCs) drive the recurrence of 
cancer in response to standard chemotherapy. These CSCs are mutated cells with core properties 
similar to those of adult stem cells. They reside in a microenvironment within the tumor tissue 
that supports their growth and make them less susceptible to drug treatment. These cells possess 
properties of self-renewal and migration, thereby driving tumor formation and metastasis. Over 
the last decade, research specifically targeting these cells has gained prominence towards 
developing new therapeutic agents against cancer. 
 
Numerous studies have demonstrated the presence of subpopulations of cells in tumors that play 
a critical role in initiating a tumor during post chemotherapy or radiation treatments (Alamgeer et 
al., 2013; Perona et al., 2011). These cells are present as a small population within the tumor and 
appear to be more potent in initiating the tumor than other subpopulations and have been 
classified as cancer stem cells (CSCs). These CSCs were characterized by independent research 
studies and were shown to sustain their malignant phenotype against drugs targeting cancer 
(Berns, 2005; Kratz et al., 2010; Perona et al., 2011). Interestingly, these CSC subpopulations 
were found to possess stem like properties of self-renewal and differentiation similar to those 
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exhibited by somatic stem cells. Certain signaling pathways such as Hedgehog, Notch, and WNT 
that are important for maintenance of embryonic stem cells were also shown to have a role in 
putative CSCs found in the lung (Hassan et al., 2013; He et al., 2005; Singh et al., 2012; Zhang 
et al., 2013; Zhang et al., 2012). Thus the discovery of CSCs has opened a new area of research 
in cancer that focuses on understanding and targeting the cells that drive the recurrence of tumor 
and metastasis.  
CSCs share similarities with the resident somatic stem cells in their respective tissues of origin. 
Somatic stem cells are characterized by their oligopotent property, where they continuously 
renew themselves as well as differentiate into distinct descendants that are specific to a tissue. 
Somatic stem cells are found along with specialized cells of an adult tissue or organ as rare side 
populations. For prolonged periods of time they reside in quiescence (G0/resting) phase of the 
cell cycle, a stage that is an actively controlled phase involving various epigenetic, 
transcriptional, and signaling pathways (Cheung and Rando, 2013). In response to injury or 
stimuli, these somatic stem cells enter mitosis and give rise to a stem cell and a progenitor cell by 
the process of asymmetric cell division. The stem cell resides back in quiescence stage until the 
next signal to re-enter the cell cycle, while the progenitor cells undergo a series of amplifications 
that give rise to post mitotic differentiated cells in respective tissues or organs of an animal. This 
characteristic asymmetric division not only plays a role in maintaining homeostasis in adult 
tissues by replacing the dead or aging cells, but also avoids repetitive entry of stem cells into the 
cell cycle, which may increase the chance of DNA damage. This similar kind of hierarchy is 
observed in CSCs, where a side population of cells forms the backbone to drive relapse of tumor 
and metastasis. However, unlike normal somatic stem cells these CSCs possess abnormal 
characteristics which are currently being explored in the context of understanding their role in 
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specific cancers. A broad perspective and future directions in identifying cancer stem cells, in 
vitro and in vivo assays to characterize them, and developing drug screening strategies have been 
critically discussed (Beck and Blanpain, 2013; Clarke et al., 2006; Liao et al., 2014). 
 
Identification and isolation of these CSCs from the bulk of tumors have been reported based on 
presence of specific markers that differ from those used to identify adult lung stem cells have 
been recently reviewed (Alamgeer et al., 2013). The phenotypic characterization of CSCs 
include the activity of cytoplasmic enzyme aldehyde dehydrogenase (ALDH)(Jiang et al., 2009), 
expression of cell surface markers CD133 and CD44, or capacity of cells to efflux membrane 
permeable dyes such as Hoechst 33342 dye and existing as a side population (SP) in bulk of 
tumor cells (Ho et al., 2007). CD133 has been identified to be a putative marker for NSCLC and 
SCLC, while CD44 is found to be enriched only in NSCLC and not in SCLC. Similarly, NSCLC 
demonstrate positive activity for ALDH. (Chen et al., 2008). Identifying a panel of universal 
markers to classify CSCs is an active area of research. Signaling pathways such as Hedgehog 
(Hh), Notch, and WNT are important in the maintenance of stem cells and tissue homeostasis are 
also found active in CSCs(Alamgeer et al., 2013). It is believed that dysregulation of these 
pathways in CSCs could drive their tumorigenic activities with several reports focused on 
developing therapeutic strategies to target these pathways. For example, inhibiting Hh signaling 
pathway in lung cancer cell lines resulted in loss of side population cells, while targeting Notch 
and Wnt signaling resulted in reduction of ALDH positive tumor cells or induction of apoptosis 
or growth inhibition in NSCLC (He et al., 2004; Sullivan et al., 2010; Tian et al., 2012).. These 
clinical trials provide some novel developments in treating lung cancer but further trials are 
needed to demonstrate efficacy. Despite these encouraging clinical results in treating cancer, 
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other mechanisms that are being discovered in CSCs still need to be further researched to 
develop feasible therapies. One such key mechanism is the Epithelial-mesenchymal transition 
(EMT) in CSCs, first reported in breast cancer stem cells (Mani et al., 2008), where the CSCs 
were shown to exploit this EMT mechanism that is normally observed during developmental 
process of the mesoderm. It involves a process by which the epithelial cells lose their 
morphology and gain migratory and invasive properties to become mesenchymal cells. This 
EMT mechanism was found to be activated during cancer invasion and metastasis and results in 
the generation of mesenchymal cells that express the stem cell marker CD44 and form tumors 
effectively in mammary epithelial cancer cells (Mani et al., 2008) and believed to be associated 
with drug resistance and cancer progression. Our current understanding is limited on signaling 
pathways and transcriptional factors that takes place in these CSCs. Expression of EMT 
associated genes is also being assessed in the context of lung cancer, but the role of EMT in 
progression of lung cancer is yet to be established (Xiao and He, 2010).  
 
1.5 Lung cancer and role of tumor protein p53 
In normal cells, p53 is expressed at low levels but as a result of stress or cellular damage, it 
activates a host of different proteins that are involved in cell cycle, apoptosis, and senescence, 
thereby preventing proliferation of cells that carry mutations or DNA damage. In unstressed 
cells, p53 function is regulated by its specific target murine double minute 2 (MDM2) by a 
process of ubiquitination. MDM2, an E3 ubiquitin-protein ligase, binds N-terminal 
transactivation domain of p53, thus mediating p53 degradation by nuclear and cytoplasmic 
proteasomes. This constant mono-ubiquitination by MDM2 regulates physiological levels and 
functions of p53 in normal cells (Moll and Petrenko, 2003). Apart from known functions of p53, 
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recent evidence suggests that p53 plays a crucial role in regulating stem cell homeostasis 
(Bonizzi et al., 2012). Studies involving re-programming of differentiated cells into induced 
pluripotent stem cells have noted that inhibition or loss of p53 increases the reprogramming 
efficiency by 3 to 10 fold (Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009). These 
studies indicate that p53 has a pivotal role in restricting the reprogramming process. Other 
studies involving adult mammary stem cells derived from p53-/- mice were shown to possess 
immortal behavior by increased self-renewal and symmetric division as opposed to limited self-
renewal and asymmetric division observed in their wild type counterparts (Cicalese et al., 2009). 
Similarly in hematopoietic stem cells (HSC), expression of p53 has been found to be critical for 
regulation of several aspects of HSC behavior. Deletion of p53 in mice was also shown to 
contribute to increased HSC self-renewal as well as an increase in the HSC pool (Liu et al., 
2009). In HSCs, p53 was also found to regulate cellular response to oncogene expression in 
progenitor cells, where absence of p53 and expression of proto-oncogene KRAs was found to 
promote acute myeloid leukemia (Zhao et al., 2010).  A recent study in hematopoietic stem cells 
and mammary stem cells has noted that DNA damage by irradiation induces up regulation of 
p21, a known target of p53 , thereby impeding apoptosis , cell cycle progression with symmetric 
cell divisions (Insinga et al., 2013). These studies indicated that elevated levels of p21 prevent 
p53 activation and its basal activity, thus preventing stem cells from apoptosis, and allowing 
them to enter the cell cycle. This study identified a unique mode of p21-dependent response to 
DNA damage in stem cells wherein p21 activates DNA repair, minimizing DNA damage 
accumulation, and exhausting the stem cells to divide symmetrically as opposed to less stressful 
asymmetric division (Insinga et al., 2013). In summary, these studies suggest that, apart from its 
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normal functional role in tumor suppression and cell cycle regulation, p53 is able to restrain adult 
stem cell self-renewal, and impose asymmetric mode of cell division.  
The loss of tumor suppressor function of p53 is either impaired by deletion of Tp53 gene or 
expression of mutated p53 protein. Alternatively, in some human cancers even though wild type 
p53 is active, its function is diminished by its primary cellular inhibitor, MDM2. These 
functional disparities are the most commonly observed causes of cancers in humans. MDM2 has 
a dual function towards p53, by acting as a positive regulator of p53 by interacting with p53 
mRNA when the ATM (Ataxia telangiectasia mutated) pathway is active. As the ATM activity 
ceases, MDM2 acts as a negative regulator to suppress the p53 protein activity by mediating its 
degradation under normal conditions (Gajjar et al., 2012). 
 
The incidence of p53 missense mutations (70%) is highest in lung cancer compared to all cancer 
types. Approximately 90% of these p53 mutations are missense mutations that result in 
accumulation of mutant p53 protein (Govindan et al., 2012; Govindan R, 2014). These impact 
molecular activity of cells and cause novel tumors not commonly observed in p53-/- (p53 null) 
cancerous mice. These missense mutation effects have been explained based on two primary 
models: dominant negative (DN) activity or oncogenic gain-of-function (GOF) (Olive et al., 
2004). In the first model, it is proposed that the mutant protein forms a hetero tetramer with wild 
type p53 and exerts a dominant negative effect on wild type p53 function. In the second model, it 
is projected that the mutant allele confers oncogenic progression irrespective of the wild type p53 
allele counterpart. Studies carried out to understand the GOF mutations by transforming p53 null 
mice with mutant p53 constructs have supported the effects based on the GOF model. 
Phenotypic characteristics ascribed to GOF activity of mutant p53 include increased 
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tumorigenicity, growth rate, motility, metastasis, invasiveness and decreased sensitivity to 
chemotherapeutic drugs (Olive et al., 2004). Understanding the changes in these cancer lines 
with GOF activities is basically proposed as an important area of research for drug targeting. 
Towards use in these studies, many researchers have generated p53 mutant mouse models (Olive 
et al., 2004) and human cell line models based on mutations reported by research studies 
complied in IARC TP53 database (http://www-p53.iarc.fr/). Recent studies have also highlighted 
the use of lentiviral approaches (endogenous expression) or transfections (transient expression) 
to express tumor-derived mutant p53 in cells (Vaughan et al., 2013).. It is observed that these 
p53 mutants show enhanced expression of NF-kappaB2 and receptor tyrosine kinase AXL (Scian 
et al., 2005; Vaughan et al., 2012b) that could be potential targets for therapies. However, 
mechanisms underlying these differential expression are unclear and yet to be defined.  
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Figure 1-3: Schematic representation of conditional point mutations in p53 gene exons 
In this study, 2 different types of p53 point mutations expressing mice and a p53+/+ wild type 
mice were employed. The targeting vector were constructed by specific mutations in the codon 
region of endogenous p53 at exon 5 for p53R172H/+ and at exon 2 and 5 for p53QSH/+ (red color). 
To induce stage specific expression lox-Stop-lox (LSL) element (yellow color) is introduced in 
the intron location. 
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Figure 1-4: Schematic representation of point mutations in p53 protein domain structure  
Point mutations in the expressed p53 protein of the respective mice carrying the engineered p53 
constructs are represented above. The targeting vector carrying p53R172H/+ mutation express a 
point mutation in the DNA binding domain of the p53 protein, where arginine is replaced by 
histidine at position 172 (represented by red line). Similarly, the targeting vector carrying 
p53QSH/+ mutation express point mutations in the transactivation domain and DNA binding 
region of the p53 protein, where glutamine is replaced by leucine and tryptophan is replaced by 
serine at positions 25,26 and arginine replaced by histidine at position 172.   
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1.6 Summary 
Cancer stem cells are found to conserve many properties of normal somatic stem cells that relate 
to self-renewal and differentiation. Some of these mechanisms, specifically related to self-
renewal and differentiation are defining features of somatic stem cells. Along with stem-cell like 
characteristics, CSCs also carry dysregulated activities in of p53, MDM2 and pathways 
dependent on these proteins. They develop resistance to the action of drugs by activating new 
molecular mechanisms and thereby prevent apoptosis. It is thus important to understand pro-
tumorigenic effects of missense mutations and their impact on cancer progression. 
Understanding the molecular mechanisms that lead to tumorigenic properties of CSCs will 
enable us to develop effective therapeutic strategies. 
 
With the available data on lung stem cells, it is reasonable to expect that Sca-1 positive and 
lineage negative lung cells possess stem cell characteristics of differentiation and self-renewal. 
As discussed in this chapter, identification of homogenous lung somatic stem cells is still an 
active area of research. It is thus important to establish homogenous population of lung stem 
cells to understand their unique characteristics. Based on the background evidence, we propose 
to investigate the following specific aims. 
Specific  Aim (I) Comparison and correlation of Sca-1 expressing lung stem/progenitor 
cells across p53 normal and cancer-sensitized p53 mutant mice 
Experiments under this specific aim are focused to investigate the phenotype, functional and 
tumorigenic properties of Sca-1 expressing and lineage negative lung cells across p53 normal 
and cancer-sensitized p53 mutant mice backgrounds.  
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Specific  Aim (II) Isolation and characterization of lung stem/ progenitor cells based on 
Sca-1 and PDGFR-α 
Experiments under this specific aim are focused to investigate the phenotype and functional 
differences of lung cells that are lineage negative but, differentially express Sca-1 and PDGFR-α 
cell surface marker. We will characterize these sub-sorted populations for their multipotent 
ability. These results will aide us in determining the role of PDGFR-α as a potential lung stem 
cell marker.  
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CHAPTER 2:  COMPARISON AND CORRELATION OF SCA-1 EXPRESSING LUNG 
STEM/PROGENITOR CELLS ACROSS P53 NORMAL AND CANCER-
SENSITIZED P53 MUTANT MOUSE MODELS 
 
 
 
 
2.1 Abstract 
Incidence of p53 point mutations is most common in lung cancers that result in oncogenic gain 
of function (GOF). Tumor recurrence after initial treatments in cancer patients is attributed to 
presence of cancer stem cells. The role of cancer stem cells in lungs is still an area of active 
research. In this study, we characterized lung stem/ progenitor cells from cancer sensitized mice 
carrying p53 GOF mutations. Our results show that there is distinct morphological and cell 
proliferation difference between the Sca-1 expressing cells established from mice lungs carrying 
different p53 genotypes. Additionally, our results suggest that Sca-1 expressing subpopulation of 
cells are significantly higher in p53 mutant carrying mice lungs than those in p53+/+ wild type. 
We also noted that Sca-1 expressing p53 mutants show tumorigenic properties of p53 
accumulation, migration, and colony formation in non-adherent culture conditions. When the 
cells across the different genetic backgrounds were subjected to mesenchymal lineage
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 differentiation, we noted that Sca-1High p53+/+ wild type readily differentiated into adipogenic 
and osteogenic lineages. However, the mesenchymal differentiation ability of the cells isolated 
from p53 mutants is not evident compared to their wild type counterparts. Results from our 
studies demonstrate the stem cell and tumorigenic nature of Sca-1 cells carrying p53 GOF 
mutations. This study lays the foundation and rationale for elaborate cellular and molecular level 
investigation of resident stem/progenitor cells expressing p53 GOF mutations. The insights on 
these resident stem/progenitor cells will ultimately shed light on cancer progression and 
development of new therapeutics in treating lung cancer. 
 
2.2 Introduction 
Cancer is a complex disease condition which results in uncontrolled division of affected cells. It 
is caused by combinatorial or discrete events of genetic changes (Govindan et al., 2012), 
environmental exposure to chemicals and radiations (Gorlova et al., 2006; Subramanian and 
Govindan, 2007), or life style choices, such as smoking (Hecht, 1999; Travis, 2004). According 
to recent estimates of incidence and mortality rates obtained by the International Agency for 
Research on Cancer, lung cancer was the most frequently diagnosed cancer of all cancers (Ferlay 
J, 2013). The incidence and mortality of lung cancer in males is highest at 16.7% and 23.6% 
respectively (Ferlay J, 2013), which is comparable to the 2008 global statistics suggesting that 
lung cancer has been the major cause of cancer related deaths in males (Jemal et al., 2011). In 
females over the last past 5 years, the incidence of lung cancer (8.8%) ranks 3rd behind breast 
(25.2%) and colorectal (9.2%) cancer, but mortality rate ranks second (13.8%) behind breast 
cancer (14.7%) (Ferlay J, 2013; Jemal et al., 2011). Overall, these data suggest the high 
occurrence of lung cancer and the need for focused research to understand its complexity and to 
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reduce the incidence and mortality of lung cancer. Lung cancer is predominantly caused as a 
result of exposure to tobacco, with global estimates indicating that about 80% of men and 50% 
of women affected by lung cancer as a result of smoking (Ezzati et al., 2005; Ezzati and Lopez, 
2003). In non-smokers, cause of lung cancer is attributed to their genetic susceptibility 
(Govindan et al., 2012) and environmental or occupational exposure to chemicals (asbestos, 
burning coal (Subramanian and Govindan, 2007), arsenic, polycyclic aromatic hydrocarbons) or 
radiations (ultra-violet light, radon) (Gorlova et al., 2006; Jemal et al., 2011; Parkin et al., 2005). 
As a result of the exposure to carcinogenic agents in smokers and non-smokers, malignant 
transformation of normal cells takes place. This involves genetic damage and oncogenic 
signaling that eventually leads to dysregulation of normal cellular functions. Lung cancer is 
broadly classified based on their cell size as small-cell lung carcinoma (SCLC) and non-small 
cell lung carcinoma (NSCLC). More than 85% of lung carcinoma constitutes NSCLC that are 
further classified based on specific histologic typing (Travis et al., 2013). 70% of SCLC and 50% 
of NSCLC show mutations in p53 (Lane, 1992; Takahashi et al., 1989).  Tumor suppressor gene 
p53 located on chromosome 17p13 is considered as guardian of a cell genome that functions in 
repairing DNA damage in G1 phase of cell cycle, before allowing cells to progress to S-phase of 
cell division. In an event of failure to repair the DNA damage, p53 activates apoptosis pathway 
that eventually results in cell death. Research studies have indicated that p53 mutations are most 
frequent in tobacco smokers thereby suggesting p53 as a mutational hot-spot. 
 
The lung is a complex organ with a wide variety of cells with identification of stem/ progenitor 
cells with specific cell surface markers enabling researchers to characterize lung cells with 
multipotent stem cell characteristics. However, specific roles and characteristics of resident 
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stem/progenitor cells expressing Gain of Function (GOF) mutations are still unknown. In the 
present study, we present evidence for the first time the ability to isolate and establish 
stem/progenitor cells from mice lung cancer models carrying p53-GOF mutations. The single 
knock-in GOF p53R172H/+ mutation in this study is arginine substituted histidine in the DNA 
binding region of the p53 protein. The triple knock-in p53QSH/+ has substitutions in 
transactivation domain (L25Q, W26S) (Johnson et al., 2005) and DNA binding domain (R172H) 
(Olive et al., 2004; Vaughan et al., 2013). Both of these GOF mutations lead to expression of 
mutant p53 protein which results in selective disrupted biological functions. We hypothesize that 
multipotent lung stem cells (MLSCs) isolated from mice carrying p53-GOF mutations exhibit 
limited differentiation potential and higher self-renewal capabilities. Here, we report for the first 
time, morphological, phenotypical, and functional differences of MLSCs established from mice 
lungs across the different p53 backgrounds. 
 
2.3 Materials and methods 
2.3.1 Lung isolation, enzymatic digestion, and cell sorting 
The lungs were dissected from p53+/+ Wild type C57BL/6 and conditional mutants p53R172H/+ 
(Olive et al., 2004) and p53QSH/+ following the steps described (Gadepalli et al., 2013; Hegab et 
al., 2010). For the purpose of this study, lungs from two mice (n=2) were harvested from 
respective p53 backgrounds. Briefly, the mice were anesthetized by intra-peritoneal (IP) route 
and sacrificed by cervical dislocation.  Careful dissection is performed from posterior to anterior 
end of the abdomen to locate trachea near throat region. 1 ml of dispase (2U/ml) is injected after 
a slight incision made on trachea. Following the injection of dispase, the inflated lungs were 
carefully harvested along with trachea and other visceral organs. The lung lobes were separated 
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from the other body parts and incubated in sterile solution containing dispase and collagenase to 
obtain slurry of the lung tissue (Gadepalli et al., 2013). Finally, the red blood cells (RBC) and 
undigested lung tissue were separated by addition of RBC lysis buffer, rinsing in sterile PBS++ 
(with Mg2+ and Ca2+) and filtering through 0.45 µm sterile filter. The cells are counted and plated 
at 1000 cells per cm2 and expanded for 21 days. 
 
 
Figure 2-1: Schematic representation of lung isolation, digestion, and sorting. 
(i) Separation of lung lobes, mincing lung tissue, and enzymatic digestion to prepare single cell 
suspension. (ii) RBC lysis and filtration of undigested lung tissue. (iii) Rinsing in growth 
medium, cell counting and plating in appropriate tissue culture-treated flask. (iv) Collection of 
single cells in trypsin, neutralize with growth medium and PBS++ wash. (v) Fluorescent 
conjugated Antibody staining with appropriate controls, depletion of PE positive cells and FACS 
sorting of lung subpopulations differentially expressing Sca-1 (vi) Propagating cells in growth 
medium for downstream cell analysis.   
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2.3.2 Cell culture components 
As the current study aims to establish and characterize primary cells with stem cell 
characteristics following similar marker combination reported by (Hegab et al., 2010), we opted 
to use the same medium composition that was shown to be conducive for propagating these cells. 
The components for growth medium are 10% defined FBS (HyClone Laboratories, Logan, Utah 
USA), DMEM-High glucose with Glutamine & sodium pyruvate 1x Penicillin/Streptomycin, 1x 
NEAA. Splitting of cells was carried at near confluence with 0.25% trypsin. Cryopreserved cell 
stocks were prepared at regular passages using freezing medium containing 10% DMSO and 
30% defined FBS. All reagents were obtained from Life Technologies (Grand Island, NY, USA) 
unless otherwise noted. 
 
2.3.3 FACS sorting and analysis of cell surface marker expression 
The goal of the study is to establish lung stem/progenitor cell lines from mice with different p53 
genetic background, based on expression of cell surface marker Sca-1. For this purpose, the cells 
were passaged using 0.25% trypsin, washed with PBS++ and suspended in 100 µl volume of 
PBS++ with respective concentration of conjugated antibody for staining, as described in ( 
Appendix i). The cells were incubated on ice for 30 minutes and washed twice with PBS++. 
Sorting of the stained cells is performed on BSC Aria- BD FACSAria™ II High-Speed Cell 
Sorter (BD Biosciences, Franklin Lakes, NJ, USA) at flow cytometry shared resource, VCU. For 
the current study, the cells were sorted based on the following expression of cell surface marker, 
Sca-1High, CD31neg, CD45neg and Sca-1Low, CD31neg, CD45neg. All the sorting procedures were 
conducted under sterile conditions and respective fluorophore isotype IgG control were 
employed as negative control. 
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For analysis of differential expression of Sca-1 marker across the different p53 background mice, 
unsorted cells were plated in 100 cm dish (in replicates). At near confluence, the uniform 
staining protocol was employed as described in ( 
Appendix i). The expression differences were evaluated on BD Accuri™ C6 flow cytometry. For 
this purpose, equal numbers of flow events were collected across all the samples in this study in 
replicates. Analysis was carried out using respective fluorophore isotype controls. Statistical 
differences were assessed using Students t-test and p-value <0.05 was considered significant. 
    
2.3.4 Immunocytochemical analysis for Sca-1 expression  
Sorted Sca-1High and Sca-1Low cells across all the p53 backgrounds were seeded on 0.1% gelatin 
coated glass bottom 35 mm dishes (MatTek Corporation, Ashland, MA, USA) at 2000 cells per 
well. After 24 hours or at 80% confluence, the cells were fixed with 4% PFA and stained with 
mouse Sca-1/Ly-6 primary antibody and Goat Anti-Rat IgG NL557, secondary antibody (R&D 
Systems, Minneapolis, MN, USA). The nuclei were stained with DAPI (EMD Millipore, 
Billerica, Massachusetts USA). Briefly, 10 µg/ml of primary antibody in a 300 µl of blocking 
buffer (3% goat serum in PBS+/+) was added to the cells and the plates were incubated overnight 
at 4oC. The sample were prepared for imaging by 1 hour incubation with secondary antibody, 
followed by PBS+/+ washes and nuclear stain with DAPI. Fluorescent images were acquired 
using a CoolSnap EZ camera 29 (Photometrics, Tucson, AZ, USA) mounted on a Nikon Eclipse 
TE 2000-S inverted microscope (Nikon, Melville, NY, USA) with attached image analysis 
software. All images settings were controlled for uniform acquisition between the samples. 
Specifically, uniform exposure time of 500ms was maintained across the experimental samples 
and as well as the negative controls for background subtraction. 
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2.3.5 AlamarBlue® cell proliferation assay 
The differences in propagation for Sca-1 sorted cells were determined by AlamarBlue® Cell 
viability (Life Technologies, Grand Island, NY, USA). In this study, to determine cell growth 
over a period of 7 days, the Sca-1High and Sca-1Low subpopulations across the wild type and 
mutants were trypsin passaged at confluence and cell counts were determined on BD Accuri™ 
C6 (BD Biosciences, Franklin Lakes, NJ, USA), as described in  
Appendix ii). 500 cells were plated per well in a 96-well plate in quadruplicates for respective 
lung cell lines. After allowing the cells to attach to the tissue culture plate for 4 hours the 
medium is aspirated and a fresh growth medium mixed with 10% AlamarBlue® reagent was 
added. Absorbance was measured at a wavelength of 570 nm and 600 nm using Synergy H1 
plate reader. Continuous readings were obtained every day for a period of 7 days without 
changing the growth medium. Wells with growth medium alone and growth medium plus 10% 
AlamarBlue® reagent were run as blanks. The experiment was repeated at two different passages 
and OD readings were averaged across the experiments. The percent reduction of AlamarBlue® 
reagent is calculated by the following equation,  
AR570=�A570-(A600×Ro)�×100 
Where,  
AR570 = Amount of reduced AlamarBlue® reagent  
A570 & A600 are sample absorbance at respective wavelength minus media blank 
Ro = Correction factor. This is calculated by AO 570 ÷ AO 600, where AO 570 and AO 600 are 
the Absorbance of Oxidized (AO) form of AlamarBlue® reagent, at respective wavelengths. AO 
= OD 10% AlamarBlue® in medium - OD growth medium, at respective wavelengths. 
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2.3.6 Cell cycle profile analysis  
To evaluate the percentage of actively dividing cells in Sca-1High and Sca-1Low lines established 
across the different p53 backgrounds, the cells were stained with propidium iodide. Briefly, at 
near confluence, cells were subjected to Trypsin treatment and cell counts were determined as 
described in 
Appendix ii). For use in cell cycle analysis, 5×104 cells were plated per 10 cm2 (35 mm) tissue 
culture plates. The cells were allowed to propagate for 24 -48 hours, allowed to reach 80% 
confluency, collected together after Trypsin treatment, washed with PBS++, fixed in cold 70% 
ethanol and stored at -20oC until analysis. Further, DNA is stained with 20 µg/ ml of propidium 
iodide (St. Louis, MO, USA). Equal number of events are collected across all the samples using 
BD Accuri™ C6 flow cytometry and analysis is carried using FCS Express 4. The detailed 
procedure for staining is described in Appendix. Samples were analyzed in triplicates and 
statistical significance was determined by student t-test, with p-value <0.05 considered to be 
significant. 
 
2.3.7 In-vitro scratch assay for analysis of cell migration  
The tumorigenic potential of p53 mutant backgrounds with respect to the normal wild type cell 
lines was determined by quantifying migration ability of cells. For this purpose sterile silicone 
culture inserts (ibidi LLC, Verona, WI, USA) were used, designed to create cell free gap of 500 
µm. The respective wild type and mutant cell lines were passaged with trypsin, quenched in 
growth medium and cell counts determined as described in  
Appendix ii). The inserts were placed in a 12-well dish with sterile forceps. Lines were drawn on 
the external bottom surface of each well of the 12-well dish with a marker pen for proper 
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orientation during imaging. Approximately, 500 cells were plated in the culture inserts and 
placed in the incubator for 24 hours. The inserts were carefully removed with sterile forceps, 
plates rinsed in with PBS++ and fresh medium was added. At 1st time point (0 hours), images of 
the cell free gap created after removing the culture inserts was captured in proper orientation 
based on the markings created underneath the well surface. The plates were returned back to the 
incubator and images captured after 6 hours in the same orientation and at the same position 
corresponding to the earlier time point. The experiment was conducted in duplicates with 3 
points of measurement for each well. The images were captured with CoolSnap EZ camera 
(Photometric, Tucson, AZ, USA) mounted on Nikon Eclipse TE2000-S inverted microscope 
(Nikon, Melville, NY, USA). The distance of the cell free gap was measured with Nikon NIS 
Elements-Br imaging software between two time points. A total of nine measurements were 
acquired for each cell line and statistical significance was determined by student t-test. The 
migration rate (µm/hr.) was calculated using the following formula.  
 
Migration rate �
µm
hr
�=
Starting distance (µm) - Final distance(µm)
Time (hours)
 
 
2.3.8 Soft agar non-adherent cell culture assay  
The tumorigenic potential of the p53 mutant cell lines was determined by their ability to form 
spheres in anchorage independent culture conditions. For this purpose, 1% pure agarose 
(BioExpress, Kaysville, UT, USA) was autoclaved and appropriate amount (2ml) was poured 
into 6-well tissue culture plate to prevent cell attachment. The cells were passaged as described 
in  
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Appendix ii and 10,000 cells were plated per well of 6-well plate. After addition of the growth 
medium, the cells were returned to the CO2 incubator and cell growth monitored for a period of 
10-14 days. 1 ml of fresh growth medium was added without replacing the old medium every 2 
days. The experiment was conducted in duplicates at two different passages. All cell colonies in 
suspension that grew in size were counted across triplicates. Statistical significance was 
determined by student t-test, with p-value<0.05 considered to be significant. 
    
2.3.9 Mesenchymal lineage differentiation analysis 
The multipotent differentiation capability of the Sca-1High and Sca-1Low lines established across 
the different p53 backgrounds was evaluated by their ability to differentiate into osteogenic and 
adipogenic lineage. For osteogenic differentiation, 10,000 cells were plated per well of a 12-well 
tissue culture plate in growth medium. At 70 % confluence, the growth medium is replaced with 
osteogenic differentiation medium containing 10nM Dexamethasone, 50 µM L-Ascorbic acid 2-
phosphate and 20mM ß-Glycerophosphate disodium salt hydrate. The cells were propagated for 
a period of 14-21 days. At the end of the differentiation period, the cells were fixed with 4% 
Paraformaldehyde. The deposition of calcium was detected with 40 mM Alizarin red stain. For 
adipogenic differentiation, 20,000 cells were plated per well of a 12-well tissue culture plate in 
adipogenic differentiation medium containing 1:50,000 dilution of 1mM insulin and 1:10,000 
dilution of 10 µM T3. At 100 % confluence, the differentiation medium is replaced with 
adipogenic induction medium containing 0.125M Indomethacin, 2mg/ml dexamethasone, 0.25M 
IBMX along with 1mM insulin and 10 µM T3. The cells were induced in the induction medium 
for 2 days and later maintained in adipogenic differentiation medium for 5 more days. At the end 
of differentiation, the cells were fixed in 10% formaldehyde. The formation of lipid droplets was 
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detected with Oil Red O staining solution. Further details of the differentiation protocol and 
staining procedure are described in Appendix iii. All reagents were obtained from Sigma (St. 
Louis, MO, USA) unless otherwise noted. 
 
2.3.10 RNA isolation, real time reverse transcription polymerase chain reaction, and gene 
expression analysis.  
To quantitate expression of genes of interest listed in Appendix iv, cell pellets were collected and 
RNA purification was performed using AllPrep DNA/RNA Mini Kit following manufacturer 
instructions (Qiagen, Valencia, CA, USA). The RNA concentration of the samples was 
determined by Nanodrop 2000c spectrophotometer (Thermo scientific, Wilmington, DE, USA) 
and 1µg of RNA across all the sorted cell lines was converted into cDNA using High-Capacity 
cDNA Reverse Transcription Kit (Life Technologies, Grand Island, NY, USA ). Q-PCR reaction 
was setup using iTaq Universal SYBR Green supermix (BioRad, Hercules, CA, USA) with 
appropriate concentration of primer and cDNA. The primer efficiencies of the internal control 
(GAPDH) and genes of interest were determined by a standard curve. Gene expression data (in 
triplicates) were acquired using CFX 96 real time system (C1000 touch). Details of the q-PCR 
setup and protocol are described in  
Appendix v). GAPDH was run as a housekeeping reference gene and analysis was performed by 
normalizing the expression quantity of gene of interest to the expression quantity of internal 
control gene using the relative standard curve method (Livak and Schmittgen, 2001; Schmittgen 
and Livak, 2008). Statistical significance was determined by student t-test, with p-value <0.05 
being considered as significantly different. 
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2.3.11 Western blot analysis 
To determine the expression of p53 protein in the sorted Sca-1High and Sca-1Low lines established 
across the different p53 backgrounds, cells were plated at 5000 cells per cm2 in respective 60 
mm (area 20 cm2) tissue culture plate and propagated to 90% confluence. Cells were collected in 
trypsin, quenched, washed with PBS++, and cell pellets placed on ice. Protein extraction was 
performed using RIPA lysis buffer following the supplier protocol. Protein concentrations were 
determined using Bradford assay. The crude protein lysate obtained across the different cell lines 
were probed for expression of p53 and ERK-2 by Western blot using specific antibodies (Santa 
Cruz Biotech, Dallas, Texas, USA). Anti-rabbit HRP-conjugated antibody was used as secondary 
antibody (CST, Danvers, MA, USA). Detection was carried out by developing the membrane in 
with ECL substrate solution (Thermo scientific, Wilmington, DE, USA) and images were 
captured using Gel Doc™ XR+ system (BioRad, Hercules, CA, USA). 
  
2.3.12 Genotyping assay by PCR 
DNA isolation and purification was performed using AllPrep DNA/RNA Mini Kit following 
manufacturer instructions (Qiagen, Valencia, CA, USA). Standard PCR reaction was setup with 
appropriate concentration of 3 primers, DNA and reagents. The genotyping strategy is to span 
the LoxP site in the mutant and to distinguish them from wild type. The PCR products were run 
on a 2% agarose gel to determine genotype of the wild type or mutant cell lines based on 
presence or absence of LoxP. Detailed description of the protocol can be found in  
Appendix v). 
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2.3.13 Colony formation assay  
To determine the colony forming ability of sorted cells, cells were plated at low density 5 cells 
per cm2 on inactivated mouse embryonic fibroblasts (iMEFs) and allowed to propagate for 7 
days. The cells were collected in trypsin, quenched in growth medium and cell counts 
determined as described in  
Appendix ii). Later, they were fixed in 10% ice cold methanol and colonies were stained with 
1% crystal violet solution (Sigma, St. Louis, MO, USA).    
 
2.4 Results 
2.4.1 Sca-1 expressing putative lung stem cells across p53 backgrounds  
Taking into consideration the complex nature of the lung and based on previous studies(Hegab et 
al., 2010; Kim et al., 2005; McQualter et al., 2009), we expect that Sca-1pos, [hematopoietic 
(CD45neg) and endothelial (CD31neg)] linneg cell population comprises more than one type of 
putative lung stem/progenitor cells. Additionally, with increasing evidence of two different 
subpopulations within the Sca-1pos cells, it is important to compare and characterize them for a 
better understanding of lung biology. Towards use in this comparative study, single cell 
suspensions were obtained by enzymatic digestion of lungs (n=2) dissected from mice from 
different p53 genetic backgrounds. Since the population of linneg and Sca-1pos cells in lungs were 
determined to be a rare subpopulation, we plated the unsorted single cells into an appropriate 
tissue culture (TC) flask (T75) and propagated them with regular growth medium changes. In 
order to minimize cell culture induced changes in in vitro conditions, we avoided splitting and 
expanding the population before sorting. We noted that the unsorted lung cells obtained from the 
mutant p53 background mice reached confluence in about 15-20 days while the p53+/+ wild type 
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cells took more than 20 days to reach confluence. After enriching the unsorted lung cells, single 
cell suspensions were stained with fluorescent conjugated somatic stem cell marker Sca-1-FITC, 
and lineage markers for hematopoietic (CD45-PE) and endothelial (CD31-PE) cell surface 
markers. Linpos cells were depleted and Sca-1Low and Sca-1High subpopulations were collected 
using BD FACS Aria™ II high-speed cell sorter. Our results indicate that even though Sca-1High 
and Sca-1Low subpopulations are not distinctly concentrated in a particular region of the Forward-
scatter (FS)-area vs Side-scatter (SS)-area or on the fluorescence (FITC) dot plot, they could be 
gated as high and low expressing populations based on their spread. We noticed that the 
percentage of cells staining positive for CD45 and CD31 were lower in cell suspension obtained 
from in vitro culture than those obtained directly from lung tissue. We speculate that these linpos 
cells were loosely adhered or have limited propagation ability and were lost during growth 
medium changes. Upon sorting, the Sca-1Low and Sca-1High cell subpopulations from different 
p53 backgrounds were propagated in TC plates (35mm) with growth medium. We further 
performed immunofluorescence staining to validate our sorting strategy, as shown in (Figure 
2-3). Under uniform exposure conditions, we noted the Sca-1High populations stained positive, 
while the Sca-1Low populations were predominantly negative with few positive cells. 
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Figure 2-2: FACS sorting of Sca-1 expressing lung stem cells across p53 backgrounds 
FACS sorting is performed with appropriate gating to deplete linpos cells (CD45 and CD31) from 
single cell suspension prepared from the whole lung harvested across the respective p53 
backgrounds. The remaining lung cell subpopulations were sorted for Sca-1High and Sca-1Low and 
plated in tissue culture dish for propagation.  
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Figure 2-3: Differential Sca-1 expression in Sca-1 High and Sca-1 Low sorted cell lines  
Immunocytochemical analysis for Sca-1 shows differential staining patterns across the mutant 
and the wild type lines. The Sca-1/Ly-6 expression is show in red and nuclei were stained with 
DAPI (blue). Scale bar represents 50µm.  
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2.4.2 Sca-1 expressing lung stem cells from p53 mutants possess higher proliferation and 
self-renewal characteristics  
Our phenotypic assays on proliferation and self-renewal ability on the sorted Sca-1 
subpopulations have demonstrated differences between the wild type p53 and mutant p53 cell 
lines. Comparing morphology under inverted microscope (Nikon TS100), we did not observe 
differences in cell morphology within the Sca-1Low and Sca-1High subpopulations established 
across the respective p53 backgrounds. However, we noted distinct morphological differences 
between the p53+/+ wild and p53 mutant cell lines. The p53 wild type cell lines were more 
heterogeneous, with small spindle shaped cells and cobblestone appearances, while the mutant 
cell lines were predominantly homogenous with elongated mesenchymal cell morphology 
(Figure 2-4). This observation is supported by our quantitative-PCR studies, where significantly 
higher mRNA transcript levels of N-cadherin was observed in p53 mutant cells relative to the 
wild type. Additionally, between the Sca-1Low and Sca-1High of the mutant cell lines, Sca-1High 
subpopulations possess higher levels of N-cadherin, supporting the mesenchymal nature of the 
putative cancer stem cells (Figure 2-5). We also observed that lung subpopulations derived from 
p53 mutant background were more easily detached from the cell culture plate compared to the 
wild type subpopulation, an indicative of their mesenchymal nature. Our proliferation curves 
were determined by ability of viable cells to reduce resazurin, an active ingredient in 
AlamarBlue® reagent, into fluorescent resorufin. As indicated by proliferation curves (Figure 
2-6), the subpopulations derived from p53 mutant backgrounds possess higher proliferation 
compared to those derived from p53 wild type. This is also supported by our cell cycle analysis, 
where higher percentage cells carrying p53 mutants were analyzed to be in the S and G2/M 
phase of the cell cycle (Figure 2-7). 
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Furthermore, we investigated the self-renewal ability of the Sca-1 subpopulations to form 
colonies at low seeding density over a period of 7 days. Our results show that Sca-1 
subpopulations expressing wild type p53+/+ cells fail to form large colonies at low seeding 
density during this time, while the same subpopulations from p53 mutant mice formed distinct 
large colonies (Figure 2-8). In order to further ascertain the self-renewal characteristic of the 
lung subpopulations from different backgrounds, we quantified the expression levels of BMI-1.  
BMI1 expression plays a crucial role in self-renewal of stem cells and as well as in cancer 
progression (Siddique and Saleem, 2012). Specifically, in lungs, BMI-1 deficient 
bronchioalveolar stem cells lack self-renewal property (Dovey et al., 2008; Zacharek et al., 
2011). Moreover, BMI-1 is elevated across diverse tumor types, thus suggesting that BMI-1 
plays a key role in regulating proliferation of both stem cells and tumor cells (Dovey et al., 2008; 
Siddique and Saleem, 2012).  Our results show that Sca-1 lung subpopulations carrying p53 
mutations possess significantly higher BMI-1 levels relative to those derived from p53+/+ wild 
type mice (Figure 2-9).  We also observed significant increase in expression levels of BMI-1 
across different human lung cancer lines relative to normal human bronchiolar endothelial cells 
(Figure 2-9). Overall, our results demonstrate that Sca-1 expressing subpopulations from the p53 
mutant mice are an actively dividing and self-renewing population compared to those derived 
from p53+/+ wild type mice. 
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Figure 2-4: Lung stem cells from p53 mutant mice show distinct mesenchymal morphology. 
Distinct morphological differences are observed between p53+/+ wild type and the mutant cell 
lines. The p53+/+ wild type cells possess small spindle shape morphology and the cell lines from 
mutant backgrounds possess longer mesenchymal morphology. Scale bar 20x magnification.  
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Figure 2-5: Sca-1 expressing lung cells from mutant p53R172H/+ mice show higher N-
cadherin expression 
Relative transcript levels of N-cadherin across the p53 backgrounds and between the sorted cell 
lines (A) Sca-1 High (B) Sca-1 Low, were determined by Q-PCR and fold change was calculated 
by relative standard curve method with p53+/+ wild type as reference cell line. Results are 
presented together with standard deviation from experiment conducted in triplicates. (* = p < 
0.05). 
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Figure 2-6: Sca-1 expressing lung cells from p53 mutants show higher proliferation 
Proliferation curve of the established cell lines was determined over a period of 7 days in 
medium containing Alamar blue reagent. The percent reduction in Alamar blue reagent was 
measured by absorbance at 570 nm with 600 nm as reference. The active growth of the cells is 
proportional to the amount of Alamar blue reagent reduced. The lung sub-population established 
from p53 mutant background attained confluence at day 4 while, the p53 wild type cells reach 
confluence at day 6 Results are presented together with standard deviation from two independent 
experiments conducted in quadruplicates. (* = p <0.05).   
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Figure 2-7: Sca-1 expressing lung cells from p53 mutant mice show lower percentage of 
cells in G-1 phase and higher percentage in S and G2/M phase of cell cycle. 
The higher proliferation potential of the p53 mutant cell lines were analyzed by determining the 
cell cycle phases using propidium iodide (PI) staining and analyzed with Accuri C6 flow 
cytometry. Error bar represents standard deviation across experiments conducted in triplicates (* 
= p <0.05). 
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Figure 2-8: Sca-1 expressing lung cells from p53 mutant mice show colony formation 
ability at low seeding density  
The ability of Sca-1 subpopulations sorted across the p53 mutants to form colonies was 
evaluated by plating cells at low seeding density on inactivated mouse embryonic fibroblasts 
(iMEF). The colonies were stained with crystal violet stain after a period of 6 days. Data from 
experiment performed in triplicates was used for analysis.  
 51 
Back To Table of Contents 
 
Figure 2-9: Sca-1 expressing lung cells from mutant p53 show higher levels of BMI-1 
mRNA expression 
Relative transcript levels of BMI-1 across the p53 backgrounds were determined by Q-PCR and 
fold change was calculated by relative standard curve method with p53+/+ wild type as reference 
cell line. Results are presented together with standard deviation from experiment conducted in 
triplicates. (* = p < 0.05). 
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Figure 2-10: Higher expression of BMI-1 is observed in human lung cancer lines  
Gene expression levels of BMI-1 across the human cancer cell lines were determined by Q-PCR 
and fold change was determined by comparative Cq method with normal human bronchiolar 
endothelial (NHBE) cells as reference cell line. Results are presented together with standard 
deviation from experiment conducted in triplicates. (* = p < 0.05). 
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2.4.3 Conditional point mutant p53 are expressed in lung subpopulations that are sorted 
based on cell surface marker Sca-1   
The GOF mutations p53R172H/+ and p53QSH/+ investigated in this study are conditional 
heterozygous mutant alleles, expressing point mutations in p53 protein, and activated by Cre-
mediated recombination as described in an earlier study (Olive et al., 2004). In our study, we 
determined the genotype of these mutants and wild type by standard PCR with a 3 primer 
combination based on published protocols (Olive et al., 2004). Our results indicate the 
expression of these conditional mutants in Sca-1Low and Sca-1High sorted lung cells are as 
anticipated. Results show the PCR amplification with a 3 primer combination resulted in only a 
control product of 166 bp in p53 wild type cells, while the p53 mutant background cells express 
both the control product of 166 bp and 270 bp LOXP LSL element (Figure 2-11). We further 
determined the ability of the conditional mutants to express aberrant p53 protein that results in 
accumulation of p53 protein. As expected, Western blot analysis show that p53+/+ wild type cell 
lines did not have any p53 protein accumulation for both Sca-1High and Sca-1Low subpopulations 
(Figure 2-12). The subpopulations from the p53 mutant cell lines, p53R172H/+ and p53QSH/+, shows 
p53 protein accumulation, suggesting that alleles with point mutations in p53 are expressed in 
the engineered knock-in mice models.  
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Figure 2-11: Genotyping by PCR amplification of conditional mutant alleles results in a 
270 bp mutant product and a 166 bp control product. 
(A) PCR products run on 1% agarose gel (1) Wild type, (2) p53R172H/+, and (3) p53QSH/+ cell lines 
expressing (a) Sca-1High and (b) Sca-1Low. (L-100 bp ladder). (B) Primer combinations that yields 
the respective PCR product wild type allele (166 bp) detected by T037, T035, and (270bp) 
detected by T036, T035 flanking the LSL element.  
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Figure 2-12: Sca-1 expressing lung cells from p53 mutant cell lines show accumulation of 
p53 protein.  
Whole cell lysates were extracted from Sca-1 expressing lung subpopulations across the p53 
backgrounds and were analyzed for expression of p53 and ERK-2 (housekeeping control).  The 
conditional point mutants p53R172H/+ and p53QSH/+ show accumulation of p53 protein while the 
p53+/+ wild type show no p53 accumulation. 
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2.4.4 Cell lines from p53 mutant mice possess higher percentage of Sca-1 expressing cell 
populations 
We compared the percentage of cell populations expressing Sca-1High and Sca-1Low across 
different p53 backgrounds using flow cytometry analysis. For these comparisons, we performed 
independent flow cytometry analysis on unsorted lung cells propagated in TC plates (100 mm). 
We noted that there is a significant difference in the number of Sca-1High cells across the mice 
with different p53 genotype backgrounds. Our results indicate that approximately 75% of 
unsorted lung cells from p53R172H/+ and 74% of p53QSH/+ can be classified as Sca-1High population, 
while only 61% of p53+/+ wild types are Sca-1High (Figure 2-13). Similarly, we noted that 
percentage of Sca-1Low is significantly lower in p53 mutant cell lines, but higher (33%) in p53+/+ 
wild types. This observation was also supported by our q-PCR analysis, where Sca-1 mRNA 
transcript levels are significantly higher in the Sca-1High population in p53 mutant cell lines 
relative to the p53+/+ wild types (Figure 2-14).  
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Figure 2-13: Cell lines isolated from p53 mutant mice lung possess higher percentage of 
Sca-1 expressing cells  
Unsorted lung cells established across different p53 background were propagated in culture and 
cells differentially expressing Sca-1 were analyzed by flow cytometry. (A) Scatter plots of 
unsorted cells stained with Sca-1-FITC (y-axis) and CD45-PE, CD 31-PE (x-axis) (B) Bar plots 
show significant differences in percentage of cells expressing Sca-1, PDGFR-α between the p53 
backgrounds. (* = p < 0.05). Results were presented together with standard deviation from 3 
independent experiments. 
 
 58 
Back To Table of Contents 
 
Figure 2-14: Sca-1 expressing lung subpopulations from p53 mutant cell lines show higher 
transcript levels of Sca-1 
Q-PCR analysis of respective transcript levels of Sca-1 mRNA across the p53 backgrounds. Sca-
1 expressing lung subpopulations from p53 mutants show significantly higher mRNA levels of 
Sca-1 compared to the p53+/+ wild type. Results are presented together with standard deviation 
from experiment conducted in triplicates. (* = p < 0.05). 
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2.4.5 Sca-1 expressing lung cells from wild type p53+/+ cells show higher differentiation 
ability 
We determined the multipotent differentiation capability of the sorted cells across different p53 
backgrounds by subjecting them to conditions that lead to formation of adipocytes and 
osteocytes, considered to be traditional mesenchymal lineages. Our results show that the p53+/+ 
Sca-1High subpopulations readily differentiated compared to the Sca-1Low subpopulations. Our 
results indicate that the p53+/+ Sca-1High subpopulations show distinct Oil red O staining patterns, 
indicative of adipogenic differentiation, after a period of 10 days (Figure 2-15), while the Sca-
1Low subpopulation exhibited fewer oil droplet formation indicative of limited differentiation 
potential. Similar differentiation potential was noted when p53+/+ wild type cells were subjected 
to osteocyte differentiation conditions for a period of 14-21 days, with robust calcium deposition 
in p53+/+ Sca-1High cells than in Sca-1Low cells (Figure 2-16). However, we observed that p53 
mutant cell lines p53R172H/+ and p53QSH/+ did not exhibit adipogenic differentiation potential, with 
differentiation conditions resulting in loss of cell viability during multiple attempts (Figure 
2-15).  Under osteogenic differentiation conditions, the Sca-1Low subpopulations from the p53 
mutant cell lines exhibited distinct calcium deposition, while the Sca-1High subpopulations from 
these p53 mutant backgrounds showed some heterogeneous calcium deposition (Figure 2-16), 
indicating that the p53 mutant cell lines have propensity for osteogenic differentiation.  
Interestingly, the subpopulations from the p53 mutant mice expressed tissue specific alkaline 
phosphatase, indicative of propensity for osteogenic differentiation (Appendix vi).  
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Figure 2-15: Sca-1High lung subpopulations from p53+/+ wild type mice show distinct 
adipogenic differentiation ability 
The sorted cell lines across the different p53 backgrounds are propagated in adipogenic 
differentiation medium for 10 days. Formation of lipid vacuoles that stain with oil red o stain at 
the end of differentiation period is indicative of adipogenesis. The Sca-1High wild type 
subpopulations show distinct Oil red O droplet formation compared to the Sca-1Low lung 
subpopulations. Sca-1 expressing lung cells from p53 mutant mice exhibited loss of viability 
indicating detrimental effects of the adipogenic differentiation medium.   
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Figure 2-16: Sca-1High lung subpopulations from p53+/+ wild type mice show distinct 
osteogenic differentiation ability 
The sorted cell lines across the different p53 backgrounds are propagated in osteogenic 
differentiation medium for 21 days. Deposition of calcium that stain with Alizarin red S at the 
end of the differentiation period is indicative of osteogenesis. The Sca-1High and Sca-1Low 
subpopulation from p53+/+ wild type and Sca-1Low subpopulation from p53 mutant cell lines 
show distinct Alizarin red S staining.   
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2.4.6 Sca-1 expressing lung subpopulations from p53 mutant mice show selective 
tumorigenic effects   
The tumorigenic property of the cell lines derived from cancer- sensitized p53 mutant (p53R172H/+ 
and p53QSH/+) mice, were determined by anchorage independent growth and migration assay. Our 
results clearly indicate that subpopulations derived from p53+/+ wild type mice exhibit no colony 
forming ability in anchorage independent growth on soft agar over a period of 10 days, while the 
subpopulations derived from the p53 mutant mice demonstrated ability to form colonies and 
grow in size in anchorage independent growth conditions during the same time period. 
Specifically, Sca-1High subpopulations derived from p53 mutant mice demonstrate higher colony 
formation compared to the Sca-1Low, subpopulations (
 
Figure 2-17). To determine the migration rate, we captured images of cells in defined regions at 
0 and 6 hrs after initiation of the assay as described in the methods section (Appendix vii). Our 
observations indicate that the subpopulations from the p53+/+ wild type and p53QSH/+ mice 
possess a similar migration rate, while the subpopulation from the p53R172H/+ mice exhibited a 
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significantly higher migration rate (Figure 2-18); Overall, our results at the in vitro level indicate 
that subpopulations derived from the cancer sensitized p53 mutant mice exhibited tumorigenic 
properties. However, our observations indicating differences existing between subpopulations 
derived from different cancer-sensitized p53 mutant mice is noteworthy and alludes to potential 
differences in tumorigenic properties based on specific p53 mutant genetic backgrounds. 
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Figure 2-17: Sca-1 expressing lung cells from p53 mutant mice show anchorage 
independent growth 
 Colonies formed by lung sub-populations across different p53 backgrounds and histogram 
representing the total number of colonies counted after 14 days in culture. (A) Sca-1 High (B) Sca-
1 Low. Data represented across two independent experiments conducted in replicates. (* = p < 
0.05, ** = p < 0.01). 
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Figure 2-18: Sca-1 expressing lung cells from p53R172H/+ mutant mice show higher 
migration rate 
Sca-1 expressing subpopulations across different p53 backgrounds were cultured to confluence 
in wells of silicone culture inserts with defined cell free gap of 500 µm. The monolayer is 
denuded by carefully lifting the inserts and distance between the denuded areas was measured at 
0 and 6 hrs. Migration is shown pictorially at 20x magnification (A) and migration rate 
graphically (B). Data represented across experiments conducted in triplicates and error bars 
represent standard deviation. (* = p < 0.05). 
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2.5 Discussion 
Treatment of cancer requires elimination of all tumor cells that are capable of regenerating 
tumors. A better understanding of tumor-recapitulating cells that are considered to be cancer 
stem cells is essential for development of successful cancer therapies. Studies have shown that 
characteristics of cancer stem cells vary with the genotype of the cancer (Curtis et al., 2010). 
While some studies have shown the role of CD133 expressing lung cancer stem cells in tumor 
regeneration (Chen et al., 2008; Eramo et al., 2008); there is also evidence for tumor-
recapitulating ability of Sca-1 expressing lung cells (Curtis et al., 2010). Here we analyzed lung 
cells differentially expressing Sca-1 across different p53 genotype backgrounds and 
characterized the nature of these Sca-1 expressing cells in in vitro conditions. The heterozygous 
mutant genotypes in this study, p53R172H/+ and p53QSH/+, were previously shown to possess tumor 
spectrums different from p53+/- and p53Null mutants (Olive et al., 2004; Vaughan et al., 2012a). 
The heterozygous and homozygous targeted point mutations in the p53 allele were reported to 
possess high frequency of metastasis and distinct carcinoma development. In spite of an active 
wild type p53 allele, these genotypes show tumor characteristics indicating a dominant negative 
effect of the point mutation (de Vries et al., 2002). Since p53 point mutations result in expression 
of mutant p53 protein, which prevents binding of p53 to DNA or MDM2 (de Vries et al., 2002; 
Olive et al., 2004; Vaughan et al., 2012b), analysis of subpopulations derived from these 
backgrounds in the context of lung cancer merits further attention.  
 
Our study investigated the selective effects of these point mutations in Sca-1 expressing lung 
cells which were shown to possess demonstrable self-renewal and differentiation characteristics 
in normal lung stem cells (Hegab et al., 2010; Kim et al., 2005; McQualter et al., 2009). Our 
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work indicates that the Sca-1High expressing lung cell subpopulation is significantly higher in p53 
mutant mice when compared to the p53+/+ wild type mice, suggesting increased numbers of Sca-
1 expressing cells in cancer sensitized p53 mutant backgrounds. A similar observation of 
increased number of Bronchioalveolar stem cells (BASC) in Lox-K-ras mice with atypical 
adenomatous hyperplasias (AAH ) and adenomas was noted (Kim et al., 2005) and were found to 
play a role in tumor initiation in vivo (Curtis et al., 2010; Kim et al., 2005). While we did not test 
the tumor-initiating capabilities of the Sca-1High and Sca-1Low subpopulations derived from 
cancer-sensitized p53 backgrounds in vivo, we have successfully demonstrated the tumorigenic 
properties of these cells. Sca-1High cells across both the p53 mutant genotypes have demonstrated 
higher proliferation, anchorage independent growth, and migration, indicative of their 
tumorigenic properties. Our results also confirm p53 accumulation in the protein lysates obtained 
from subpopulations derived from both mutant backgrounds, validating the expression of mutant 
p53 protein. Even though our tumorigenic assays demonstrate the higher tumorigenic potential of 
the subpopulations derived from the p53R172H/+ mice, these cell lines expressed low amount of 
p53 protein compared to those derived from p53QSH/+ mutant mice. Our observations indicating 
low levels of p53 accumulation in Sca-1 sorted cells from p53R172H/+ cell lines could be attributed 
to the presence of an altered splice acceptor site in p53R172H/+, that results in reduced expression 
of the mutant p53 protein (de Vries et al., 2002; Olive et al., 2004). B cell-specific Moloney 
murine leukemia virus integration site 1 (BMI-1) protein has been shown to play a critical role in 
self-renewal and differentiation of somatic stem cells in lung and other tissues (Siddique and 
Saleem, 2012; Zacharek et al., 2011). Conclusions based on numerous studies indicate the role of 
BMI-1 in progression, recurrence, and chemo-resistance of cancer cells. Our analysis of BMI-1 
expression across cancer sensitized p53 mutants and p53+/+ wild type genotypes indicate that p53 
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mutant cell lines express significantly higher BMI-1 mRNA levels. This higher mRNA levels 
correlates to the observed tumorigenic properties, supporting the significance of BMI-1 
expression in cancer sensitized p53 mutant cell lines. 
 
Tissue specific adult stem cells exhibit self-renewal, a process by which stem cells divides to 
make more stem cells, in order to maintain the stem cell pool throughout the lifespan. The role of 
proto-oncogenes and tumor suppressor genes in controlling cell cycle, balancing self-renewal 
and differentiation have been studied with results indicating that proto-oncogenes promote self-
renewal, while gate-keeper tumor suppressors limit self-renewal and care-taker tumor 
suppressors maintain genomic integrity (He et al., 2009).  The p53 gene exhibits both gate-
keeper and care-taker functions (Jerry et al., 2008) and it is reasonable to expect that point 
mutations result in disruption of both these functions. The Sca-1 expressing lung stem cells in 
this study were sorted from  mice carrying p53R172H/+, a model for Li-Fraumeni syndrome (Olive 
et al., 2004), and p53QSH/+with compromised transactivation ability to induce apoptosis (Johnson 
et al., 2005; Vaughan et al., 2013).  We tested the stem cell properties of Sca-1 expressing lung 
stem cells by assessing their multipotent differentiation ability into mesenchymal lineage. Sca-
1High and Sca-1Low subpopulations from p53+/+ wild type mice exhibited differentiation potential 
into adipocytes and osteocytes, while those derived from p53 mutant mice exhibited limited 
differentiation abilities.  Our results also indicated that the adipocyte differentiation medium has 
detrimental effects on the subpopulations derived from the cancer sensitized p53 mutant mice, 
resulting in restricted growth and loss of cell viability. Our observations of loss of cells under 
adipogenic differentiation conditions are similar to what has been observed by experiments 
conducted on putative stem cells isolated from prostate cancer cells (Zhau et al., 2011). Based on 
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our findings, we conclude that further studies need to be conducted to investigate the uni- and 
multi- potent differentiation ability of these cells into specific lung lineages and other lineages.  
 
In summary, our study highlights the existence of higher number of Sca-1 expressing putative 
lung stem cells in cancer sensitized p53 mutant mice. Additionally, phenotypic and functional 
studies support their tumorigenic properties and limited differentiation ability, suggesting that the 
increase in Sca-1 population can be correlated to p53 mutations.  Future in vivo studies are 
needed to further confirm the stem cell nature, self-renewal and differentiation, as in vivo studies 
captures the natural stem cell niche.  The tumor initiating role of the Sca-1 expressing lung stem 
cells needs further validation in vivo to investigate the importance of Sca-1 expressing cells from 
p53 mutant backgrounds as cancer stem cells.  Detailed characterization of these putative cancer 
stem cells is expected to lead to the development of chemoprevention strategies for treating lung 
cancer.       
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CHAPTER 3:  ISOLATION AND CHARACTERIZATION OF LUNG 
STEM/PROGENITOR CELLS BASED ON SCA-1 & PDGFR-ΑLPHA 
 
 
 
 
3.1 Abstract 
The lung consists of different anatomically defined regions composed of large airways (bronchi), 
bronchioles, and alveoli that harbor morphologically and functionally distinct mesodermal and 
endodermal cell types. Within these complex structures, studies have shown the existence of 
candidate cells that exhibit stem cell characteristics of self-renewal and differentiation. 
Identification of Sca-1 expressing lung cells has been the most common approach in isolation of 
these resident lung/ stem progenitor cells. To reduce cellular heterogeneity, studies have focused 
on combination of different cell surface markers along with Sca-1 to identify and characterize 
stem/progenitor cells with defined stem cell characteristics. Here we incorporated a two marker 
strategy to identify and characterize lung cells differentially expressing Stem cell antigen-1 (Sca-
1) and Platelet derived growth factor-alpha (PDGFR-α). By employing fluorescence-activated 
cell sorting (FACS), we have established multiple subpopulations of cells from the murine lung 
and evaluated their phenotypic and functional properties. Our results suggest that except for Sca-
1LowPDGFR-αHigh subpopulations, all the subpopulations possess mesenchymal differentiation
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 potential into adipocytes and osteocytes, suggesting that Sca-1LowPDGFR-αHigh subpopulation 
lacks stem cell characteristics. We also noted that these subpopulation possess higher 
proliferation, and high N-cadherin expression indicating their mesenchymal nature. On the 
contrary, we observed robust differentiation ability in both Sca-1HighPDGFR-αHigh and Sca-1High 
PDGFR-αLow subpopulations, but lower proliferation ability in the latter. Initial FACS analysis in 
p53 mutant lines indicate the presence of a high percentage of Sca-1HighPDGFR-αHigh 
subpopulation, which alludes to the importance of PDGFR-α as a potential cancer stem cell 
marker. Overall, our results demonstrate the potential use of PDGFR- α in sorting for 
subpopulations with defined stem cell characteristics and to further determining its importance in 
the context of lung cancer. 
  
3.2 Introduction 
Understanding the role of somatic stem cells in different tissues to maintain homeostasis and 
wound healing is still an area of active research. Numerous studies have uncovered existence of 
different somatic cells, non- hematopoietic stem cells, with multipotent characteristics in various 
tissues and organs, including lungs (Lundin and Driscoll, 2012; Stappenbeck and Miyoshi, 
2009).  Identification of homogenous stem cell populations in the lung is a challenge since lung 
encompasses approximately 40 different types of cells with distinct functions (Filby, 2012; 
Kajstura et al., 2011).There has been increasing evidence showing lung stem cells with self-
renewal and differentiation capability in mouse models, based on unique combinations of 
specific cell surface marker profiles (Raiser and Kim, 2009; Stripp BR, 2011). Studies have 
demonstrated that lung cells expressing Sca-1 were predominantly found in distal regions of 
lungs and were shown to possess a temporal emergence, indicated by enrichment of Sca-1 
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expressing cells in adult mouse lungs when compared to neonatal lungs (McQualter et al., 2009). 
These Sca-1pos lung subpopulations established from adult mice lungs were shown to possess 
stem cell characteristics of self-renewal and differentiation. Based on the expression of Sca-1 and 
other markers, various studies have identified unique subpopulations in adult lung that possess 
stem cell characteristics (Hegab et al., 2010). Thus Sca-1 emerged as a representative cell surface 
marker to identify the lung stem cells. An important area of research is the identification of novel 
cell surface markers that would aid in distinguishing lung stem cells and progenitor cells as well 
as to isolate a homogenous population of these cells. Identification of endogenous lung stem 
cells and progenitors not only aids in a fundamental understanding of lung biology, but also can 
contribute to applications in regenerative medicine for treating lung diseases such as pulmonary 
hypertension and chronic obstructive pulmonary diseases (Lau et al., 2012; Weiss, 2014). 
 
Isolation of a subpopulation from the bone marrow based on expression of both Sca-1 and an 
early mesodermal marker platelet-derived growth factor receptor α (PDGFRα) has enabled to 
establish homogenous population of mesenchymal stem cells with minimum contamination of 
hematopoietic stem cells and other cells (Morikawa et al., 2009). Lung is comprised of different 
stem cell subpopulations with characteristics that differ with respect to the method of isolation 
and choice of cell surface (Raiser and Kim, 2009).  Recent evidences points to existence of 
epithelial lung stem cells in Sca-1neg subpopulations and mesenchymal lung stem cells in Sca-1pos 
subpopulation (Hegab et al., 2010; McQualter et al., 2009). Our rationale to characterize Platelet-
derived growth factor receptor-alpha (PDGFR-α) expression in lung cells was based on studies in 
bone marrow (Houlihan et al., 2012) and heart (Chong et al., 2013) which supports its role as a 
potential mesenchymal stem cell marker. In this study, we have characterized lung stem cells 
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based on expression of Sca-1 and PDGFR-α cell surface markers. We hypothesize that lung cells 
consist of subpopulations that differentially express PDGFR-α and Sca-1 with different stem cell 
characteristics of self-renewal and differentiation. Here, we report for the first time, 
morphological, phenotypical, and functional differences of subpopulations that point to a role for 
PDGFR- α in sorting for subpopulations with defined stem cell characteristics and to further 
determining its importance in the context of lung cancer.      
  
3.3 Materials and methods 
3.3.1 Lung isolation, enzymatic digestion, and cell sorting  
For the purpose of this study, lungs (n=2) were dissected from p53+/+ Wild type C57BL/6 
following the steps described (Gadepalli et al., 2013; Hegab et al., 2010). Briefly, the mice were 
anesthetized by intra-peritoneal (IP) route and sacrificed by cervical dislocation.  Careful 
dissection is performed from posterior to anterior end of the abdomen to locate trachea near 
throat region. 1 ml of dispase (2U/ml) is injected after a slight incision made on trachea. 
Following the injection of dispase, the inflated lungs were carefully harvested along with trachea 
and other visceral organs. The lung lobes were separated from the other body parts and incubated 
in sterile solution containing dispase and collagenase to obtain slurry of the lung tissue 
(Gadepalli et al., 2013). Finally, the red blood cells (RBC) and undigested lung tissue were 
separated by addition of RBC lysis buffer, rinsing in sterile PBS++ (with Mg2+ and Ca2+) and 
filtering through 0.45 µm sterile filter. The cells are counted and plated at 1000 cells per cm2 and 
expanded for 21 days. 
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Figure 3-1: Schematic representation of lung isolation, digestion, and cell sorting. 
(i) Separation of lung lobes, mincing lung tissue, and enzymatic digestion to prepare single cell 
suspension. (ii) RBC lysis and filtration of undigested lung tissue. (iii) Rinsing in growth 
medium, cell counting and plating in appropriate tissue culture-treated flask. (iv) Collection of 
single cells in trypsin, neutralize with growth medium and PBS++ wash. (v) Fluorescent 
conjugated Antibody staining with appropriate controls, depletion of PE positive cells and FACS 
sorting of lung subpopulations differentially expressing Sca-1 PDGFR-α. (vi) Propagating cells 
in growth medium for downstream cell analysis.  
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3.3.2 Cell culture components  
As the current study aims to establish and characterize primary cells with stem cell 
characteristics following similar marker combination reported by (Hegab et al., 2010), we opted 
to use the same medium composition that was shown to be conducive for propagating these cells. 
The components for growth medium are 10% defined FBS (HyClone Laboratories, Logan, Utah 
USA), DMEM-High glucose with Glutamine & sodium pyruvate 1x Penicillin/Streptomycin, 1x 
NEAA. Splitting of cells was carried at near confluence with 0.25% trypsin. Cryopreserved cell 
stocks were prepared at regular passages using freezing medium containing 10% DMSO and 
30% defined FBS. All reagents were obtained from Life Technologies (Grand Island, NY, USA) 
unless otherwise noted. 
 
3.3.3 FACS sorting and analysis of cell surface marker expression 
The goal of the study is to establish lung stem/progenitor cell lines from mice with different p53 
genetic background, based on expression of cell surface marker Sca-1 and PDGFR-α. For this 
purpose, the cells were passaged using 0.25% trypsin, washed with PBS++ and suspended in 100 
µl volume of PBS++ with respective concentration of conjugated antibody for staining, as 
described in  
Appendix i). The cells were incubated on ice for 30 minutes and washed twice with PBS++. 
Sorting of the stained cells is performed on BSC Aria- BD FACSAria™ II High-Speed Cell 
Sorter at flow cytometry shared resource, VCU. For the current study, first lineage CD45 and 
CD31 positive lung cells were depleted and a 4-way gating was applied to sort Sca-1High 
PDGFR-α High, Sca-1High PDGFR-α Low, Sca-1 Low PDGFR-α High, and Sca-1 Low PDGFR-α Low 
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subpopulations of lung cells. All the sorting procedures were conducted under sterile conditions 
and respective fluorophore isotype IgG control were employed as negative control. 
For analysis of differential expression of Sca-1and PDGFR-α  expression across the different p53 
background mice, single cell suspension were obtained as described earlier and unsorted cells 
were plated in 100 cm dish (in replicates). At near confluence, the uniform staining protocol was 
employed as described in  
Appendix i). The expression differences were evaluated on BD Accuri™ C6 flow cytometry (BD 
Biosciences, Franklin Lakes, NJ, USA). For this purpose, equal numbers of flow events were 
collected across all the samples in this study in replicates. Analysis was carried out using 
respective fluorophore isotype controls. Statistical differences were assessed using Students t-test 
and p-value <0.05 was considered significant.   
   
3.3.4 AlamarBlue® cell proliferation assay 
The differences in propagation for Sca-1 and PDGFR-α expressing lung subpopulations were 
determined by AlamarBlue® Cell viability (Life Technologies, Grand Island, NY, USA). In this 
study, to determine cell growth over a period of 7 days, the respective subpopulations were 
trypsin passaged at confluence and cell counts were determined on BD Accuri™ C6 (BD 
Biosciences, Franklin Lakes, NJ, USA), as describe in  
Appendix ii). 500 cells were plated per well in a 96-well plate in quadruplicates for respective 
lung cell lines. After allowing the cells to attach to the tissue culture plate for 4 hours the 
medium is aspirated and a fresh growth medium mixed with 10% AlamarBlue® reagent was 
added. Absorbance was measured at a wavelength of 570 nm and 600 nm using Synergy H1 
plate reader. Continuous readings were obtained every day for a period of 7 days without 
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changing the growth medium. Wells with growth medium alone and growth medium plus 10% 
AlamarBlue® reagent were run as blanks. The experiment was repeated at two different passages 
and OD readings were averaged across the experiments. The percent reduction of AlamarBlue® 
reagent is calculated by the following equation,  
AR570=�A570-(A600×Ro)�×100 
Where,  
AR570 = Amount of reduced AlamarBlue® reagent  
A570 & A600 are sample absorbance at respective wavelength minus media blank 
Ro = Correction factor. This is calculated by AO 570 ÷ AO 600, where AO 570 and AO 600 are 
the Absorbance of Oxidized (AO) form of AlamarBlue® reagent, at respective wavelengths. AO 
= OD 10% AlamarBlue® in medium - OD growth medium, at respective wavelengths. 
 
3.3.5 Mesenchymal lineage differentiation analysis 
The multipotent differentiation capability of the lung subpopulations established based on 
differential expression of Sca-1 and PDGFR-α was evaluated by their ability to differentiate into 
osteogenic and adipogenic lineage. For osteogenic differentiation, 10,000 cells were plated per 
well of a 12-well tissue culture plate in growth medium. At 70 % confluence, the growth medium 
is replaced with osteogenic differentiation medium containing 10nM Dexamethasone, 50 µM L-
Ascorbic acid 2-phosphate and 20mM ß-Glycerophosphate disodium salt hydrate. The cells were 
propagated for a period of 14-21 days. At the end of the differentiation period, the cells were 
fixed with 4% Paraformaldehyde. The deposition of calcium was detected with 40 mM Alizarin 
red stain. For adipogenic differentiation, 20,000 cells were plated per well of a 12-well tissue 
culture plate in adipogenic differentiation medium containing 1:50,000 dilution of 1mM insulin 
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and 1:10,000 dilution of 10 µM T3. At 100 % confluence, the differentiation medium is replaced 
with adipogenic induction medium containing 0.125M Indomethacin, 2mg/ml dexamethasone, 
0.25M IBMX along with 1mM insulin and 10 µM T3. The cells were induced in the induction 
medium for 2 days and later maintained in adipogenic differentiation medium for 5 more days. 
At the end of differentiation, the cells were fixed in 10% formaldehyde. The formation of lipid 
droplets was detected with Oil Red O staining solution. Further details of the differentiation 
protocol and staining procedure are described in Appendix iii. All reagents were obtained from 
Sigma (St. Louis, MO, USA) unless otherwise noted.  
 
3.3.6 RNA Isolation, real time reverse transcription polymerase chain reaction, and gene 
expression analysis.  
To quantitate expression of genes of interest listed in Appendix iv, cell pellets were collected and 
RNA purification was performed using AllPrep DNA/RNA Mini Kit following manufacturer 
instructions (Qiagen, Valencia, CA, USA). The RNA concentration of the samples was 
determined by Nanodrop 2000c spectrophotometer (Thermo scientific, Wilmington, DE, USA) 
and 1µg of RNA across all the sorted cell lines was converted into cDNA using High-Capacity 
cDNA Reverse Transcription Kit (Life Technologies, Grand Island, NY, USA ). Q-PCR reaction 
was setup using iTaq Universal SYBR Green supermix (BioRad, Hercules, CA, USA) with 
appropriate concentration of primer and cDNA. The primer efficiencies of the internal control 
(GAPDH) and genes of interest were determined by a standard curve. Gene expression data (in 
triplicates) were acquired using CFX 96 real time system (C1000 touch). Details of the q-PCR 
setup and protocol are described in  
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Appendix v). GAPDH was run as a housekeeping reference gene and analysis was performed by 
normalizing the expression quantity of gene of interest to the expression quantity of internal 
control gene using the relative standard curve method (Livak and Schmittgen, 2001; Schmittgen 
and Livak, 2008). Statistical significance was determined by Student t-test, with p-value <0.05 
being considered as significantly different. 
 
3.4 Results 
3.4.1 Lung comprises of subpopulation of cells that differentially express Sca-1 and 
PDGFR-α  
In a single marker strategy to identify stem cells in the lung, Sca-1pos and linneg (CD31, CD45) 
multipotent lung stem cells constitute subpopulations of cells that are heterogeneous (Hegab et 
al., 2010). Various studies support the existence of more than one population of cells in tissues 
with high cell turnover or regeneration (Barker et al., 2010). More importantly, as widely 
elucidated in the hematopoietic system, distinguishing somatic stem and progenitor cells is 
important to understand their role in tissue homeostasis and repair. Here, we evaluated the 
characteristics of lung cells that differentially express Sca-1 and PDGFR-α post depletion of 
CD45 and CD31expressing cells. Although a previous study has reported expression of PDGFR-
α in lung cells (McQualter et al., 2009), isolation and characterization of lung cells differentially 
Sca-1 and PDGFR-α has not been studied.  
 
Our results indicate that lung cells comprise of subpopulations of cells that differentially express 
Sca-1 & PDGFR-α. We noted that after depleting the CD45posCD31pos cells, the percentage of 
cells expressing Sca-1High PDGFR-αHigh constitute around 23.2% of the total population, Sca-
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1High PDGFR-αLow constitute 5%, while Sca-1Low PDGFR-α High and Sca-1Low PDGFR-αLow 
constitute 28.5% and 26.3% respectively (Figure 3-2). In sorting based on single cell surface 
marker Sca-1, Sca-1 High expressing lung subpopulations consists of small spindle shaped cells 
mixed with large elongated cells. While sorting based on both Sca-1& PDGFR-α, lung 
subpopulations are more homogenous. Subpopulations expressing Sca-1High and either high or 
low expression of PDGFR-α constitute small spindle shaped cells. On the other hand, 
subpopulations expressing in Sca-1Low and either high or low expression of PDGFR-α  constitute 
 large elongated cells (Figure 3-3) , additional qPCR analysis of the sorted subpopulations 
indicated representative expression of Sca-1 and PDGFR-α mRNA transcript levels (Figure 3-4). 
We further evaluated the percentage of subpopulations expressing Sca-1 and PDGFR-α in 
unsorted lung cells from p53 knock-in mice and compared them to those isolated from p53+/+ 
wild type mice. Our results from flow cytometry analysis indicate that lung cells from p53 
knock-in mutants, p53R172H/+ and p53QSH/+, possess significant higher percentage (~3 fold 
increase) of subpopulations expressing Sca-1High PDGFR-αHigh compared to those from p53+/+ 
wild type mice (Figure 3-5). Interestingly, Sca-1HighPDGFR-αLow, Sca-1LowPDGFR-αLow 
subpopulations are significantly lower in lung cells isolated from p53 mutant knock-in mice. 
These results demonstrate the potential for use of PDGFR-α as an important cell surface marker 
to identify novel subpopulations in the lung.  
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Figure 3-2: FACS sorting of lung cells differentially expressing Sca-1 & PDGFR-α 
FACS sorting is performed with appropriate gating to deplete lineage positive cells (CD45 and 
CD31) from single cell suspension prepared from the whole lung harvested from normal mice. 
The remaining lung cell subpopulations were sorted for cells expressing both Sca-1, PDGFR-α 
cell surface marker and plated in tissue culture dish for propagation.  
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Figure 3-3: Subpopulations established based on both Sca-1& PDGFR-α expression 
consists of homogenous cells. 
Sorted lung subpopulations were plated in tissue culture dish and images were captured (scale 
bar 100 µm). (A) In sorting based on single cell surface marker Sca-1, Sca-1 High expressing lung 
subpopulations consists of small spindle shaped cells mixed with large elongated cells. (B) In 
sorting based on both Sca-1& PDGFR-α, Sca-1High PDGFR-α expressing ( left) lung 
subpopulations are more homogenous with spindle shaped cells while and Sca-1Low PDGFR-α 
expressing are large elongated cells.   
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Figure 3-4: Lung subpopulations established based on Sca-1& PDGFR-α expression show 
representative Sca-1 and PDGFR-α mRNA transcript levels 
Q-PCR analysis of relative transcript levels of Sca-1 and PDGFR-α across the lung 
subpopulations established based on Sca-1, PDGFR-α cell surface marker expression. Results are 
presented together with standard deviation from experiment conducted in triplicates.  
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Figure 3-5: Sca-1High PDGFR-αHigh expressing lung subpopulations are significantly 
increased in mice carrying p53 point mutations. 
Unsorted lung cells established across different p53 background were propagated in culture and 
cells differentially expressing both Sca-1, PDGFR-α (CD140-a) were analyzed by flow 
cytometry. (A) Scatter plots of unsorted cells stained with Sca-1-FITC (x-axis) and PDGFR-α (y-
axis) (B) Bar plots show significant differences in percentage of cells expressing Sca-1, PDGFR-
α between the p53 backgrounds. (* = p < 0.05). Results are presented together with standard 
deviation from 3 independent cultures. 
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3.4.2 Sca-1Low PDGFR-αHigh expressing lung subpopulation show higher proliferation 
Under the in vitro culture conditions adopted in this study, we noted that these subpopulations 
exhibit proliferation differences, with the Sca-1LowPDGFR-α High subpopulation exhibiting higher 
proliferation capability (Figure 3-8). Given that PDGFR-α is a mesenchymal lineage marker, it is 
expected that the subpopulations possess higher proliferation ability. Similarly, Sca-
1HighPDGFR-α High exhibit similar proliferation capabilities. We subsequently evaluated the 
expression levels of N-cadherin mRNA levels, a mesenchymal marker, in the different 
subpopulations. Our results indicate that the Sca-1LowPDGFR-α High subpopulation exhibit 
significantly higher levels of N-cadherin when compared to all other sorted subpopulations 
(Figure 3-7). Additionally, the Sca-1LowPDGFR-α High subpopulation expressed higher levels of 
BMI-1 transcript levels, indicating the higher self-renewal potential of these cells (Figure 3-6).  
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Figure 3-6: Sca-1Low PDGFR-αHigh expressing lung subpopulation show higher BMI-1 
transcript levels 
Q-PCR analysis of relative transcript levels of BMI-1 across the lung subpopulations sorted 
based on Sca-1 and PDGFR-α cell surface marker expression. Sca-1LowPDGFR-αHigh 
subpopulations exhibit higher BMI-1 transcript levels, indicative of higher proliferation and self-
renewal potential. Results are presented together with standard deviation from experiment 
conducted in triplicates.  
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Figure 3-7: Sca-1LowPDGFR-αHigh expressing lung subpopulation exhibit higher N-cadherin 
mRNA expression 
Q-PCR analysis of relative transcript levels of N-cadherin across the lung subpopulations 
established based on Sca-1 and PDGFR-α cell surface marker expression. Sca-1LowPDGFR-αHigh 
subpopulation exhibits higher N-cadherin transcript levels indicating its mesenchymal nature. 
Results are presented together with standard deviation from experiment conducted in triplicates.  
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Figure 3-8 PDGFR-α expressing lung subpopulation exhibit higher proliferation potential  
The sorted cells are plated at 500 cells per well in 96 well plate, and the percentage reduction of 
Alamar blue was measured by absorbance at 570 nm. Sca-1LowPDGFR-αHigh subpopulation 
exhibit higher proliferation rate when compared with the other sorted subpopulations. Results are 
presented together with standard deviation from two independent experiments conducted in 
quadruplicates. 
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3.4.3 Sca-1LowPDGFR-αHigh expressing lung subpopulation exhibit no differentiation 
ability  
Stem cells are characterized by their dual ability of self-renewal and differentiation into specific 
lineages. Demonstrating the differentiation capability after repeated passages in culture is critical 
in order to fully validate the stem cell characteristics of any derived cell line. In our study, after 
repeated passages in culture, we evaluated the differentiation potential of early and late passage 
cells to form adipocytes and osteocytes. Our results suggest that except for Sca-1LowPDGFR-α 
High subpopulation, all the sorted subpopulations possess adipogenic differentiation capabilities at 
early and late passages, demonstrated by positive Oil Red O staining (Figure 3-9 & Figure 3-10). 
In establishing lung stem/progenitor cells by use of Sca-1 alone, we noted that Sca-1High cells 
readily differentiate to adipocytes while Sca-1Low cells do not. In the 2-way sorting strategy, with 
Sca-1 & PDGFR-α, we did not observe any differentiation potential in Sca-1LowPDGFR-αHigh 
cells, while Sca-1HighPDGFR-αLow and Sca-1LowPDGFR-αLow cells exhibited robust 
differentiation. 
 
Based on calcium deposition by Alizarin Red S staining, we observed a passage number effect 
with early passage cells exhibiting osteogenic differentiation potential, while late passage cells 
do not (Figure 3-11 and Figure 3-12). It is useful to note that the sorted subpopulations exhibit 
similar osteogenic and adipogenic differentiation potentials. In single marker isolation using Sca-
1, Sca-1High cells readily differentiated when compared to Sca-1Low cells. In the 2-way sorting 
strategy, with Sca-1 & PDGFR-α, we did not observe any osteogenic differentiation potential in 
Sca-1LowPDGFR-α High lung subpopulation, while Sca-1HighPDGFR-α Low and Sca-1LowPDGFR-α 
Low cells exhibited robust differentiation. 
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Figure 3-9: Sca-1High expressing lung subpopulation show higher adipogenic differentiation  
The sorted cell lines established based on differential Sca-1 expression from normal mice were 
propagated in adipogenic differentiation medium for 10 days. Adipogenesis was indicated by 
formation of lipid vacuoles that stain with oil red o stain at the end of differentiation period. The 
Sca-1High wild type lines show distinct oil red droplet formation compared to the Sca-1Low lung 
subpopulation.   
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Figure 3-10: Sca-1Low PDGFR-αHigh expressing lung subpopulation lack adipogenic 
differentiation potential  
The sorted cell lines established based on differential expression of both Sca-1 and PDGFR-α 
were propagated in adipogenic differentiation medium for 10 days. Adipogenesis was indicated 
by formation of lipid vacuoles that stain with Oil red O stain at the end of differentiation period. 
The Sca-1HighPDGFR-αLow subpopulation exhibit robust adipogenic differentiation capacity, 
while the Sca-1LowPDGFR-αHigh lung subpopulation lack adipogenic differentiation potential.  
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Figure 3-11: Sca-1High expressing lung subpopulations demonstrate higher osteogenic 
differentiation potential  
The sorted cell lines established based on differential Sca-1 expression from normal mice were 
propagated in osteogenic differentiation medium for 21 days. Osteogenesis was indicated by 
deposition of calcium that stain with Alizarin red S at the end of the differentiation period. The 
Sca-1High wild type lines show distinct Alizarin red S staining compared to Sca-1Low lung 
subpopulation.  
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Figure 3-12: Sca-1Low PDGFR-αHigh expressing lung subpopulation lack osteogenic 
differentiation potential 
The sorted cell lines established based on differential expression of both Sca-1 and PDGFR-α 
were propagated in osteogenic differentiation medium for 21 days. Osteogenesis was indicated 
by deposition of calcium that stain with Alizarin red S at the end of differentiation period. The 
Sca-1HighPDGFR-αLow and Sca-1HighPDGFR-αHigh subpopulations exhibit robust osteogenic 
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differentiation potential, while the Sca-1LowPDGFR-αHigh lung subpopulation lacks osteogenic 
differentiation potential.   
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3.5 Discussion 
In this study, we adopted a two-marker strategy for isolation and characterization of multipotent 
stem cells from the mouse lung. Our results support the existence of a heterogeneous lung cell 
population, validating the recent evidence of multiple stem cell niches in the lung (Otto, 2002; 
Raiser and Kim, 2009). Complex tissues like the lung, although primarily epithelial in nature are 
believed to encompass both epithelial and mesenchymal stem cells (Slack, 2000; Stripp BR, 
2011). Currently, functional assays to distinguish subpopulations with stem cell characteristics in 
lungs is solely based on in vitro assays, that capture self-renewal and multipotent differentiation 
potential. For instance, Bronchioalveolar Stem Cells (BASCs) identified by expression of Sca-
1posCD34pos, were characterized as epithelial lung stem cells (Kim et al., 2005), but another 
systematic analysis of the same subpopulation classify them as fibroblastic given that these cells 
also co-express Thy-1 and platelet-derived growth factor receptor α (PDGFR- α) (McQualter et 
al., 2009). The discrepancy in the results between independent research groups was ascribed to 
isolation methods, gating strategies, and culture conditions (Hegab et al., 2010; McQualter et al., 
2009; Raiser and Kim, 2009; Teisanu et al., 2009). Existence of heterogeneous stem cell 
populations is not limited to the lung tissue alone with studies indicating co-existence of  
hematopoietic and mesenchymal stem cells in the bone marrow (Morikawa et al., 2009; Wilson 
and Trumpp, 2006). Identification of pure population of mesenchymal stem cells in bone marrow 
was achieved by employing Sca-1 and PDGFR-α cell surface markers, where Sca-1posPDGFR-
αpos  subpopulation was characterized as a homogenous population of  mesenchymal stem cells 
(Houlihan et al., 2012; Morikawa et al., 2009). Our analysis of differential expression of Sca-1 
and PDGFR-α shows the potential role of PDGFR-α as a stem cell marker in the lung tissue. 
Interestingly, our results indicate that the Sca-1LowPDGFR-αHigh lung cell subpopulation lack 
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mesenchymal differentiation potential into adipocytes and osteocytes. The results suggests that 
Sca-1posCD31negCD45neg lung cells comprise of cells that lack stem cell characteristics that can 
be further purified based on differential expression of PDGFR-α. In contrast to the results found 
in the bone marrow (Houlihan et al., 2012), the Sca-1HighPDGFR-αHigh, Sca-1HighPDGFR-αLow, 
and Sca-1LowPDGFR-αLow subpopulations from the lung exhibit mesenchymal differentiation 
potential. As expected, the Sca-1HighPDGFR-αHigh subpopulation exhibited high N-cadherin 
expression and higher proliferation indicating its mesenchymal nature. Our results thus indicate 
the potential role of PDGFR-α as a stem cell marker in lungs. We acknowledge the limited 
functional assays to systematically discern these subpopulations as stem and progenitor cells, 
thus indicating a need for development of more comprehensive experimentation to identify 
hierarchy of stem cell populations in lung (Lau et al., 2012; McQualter et al., 2009; Raiser and 
Kim, 2009). Developing in vitro assays that capture the in vivo conditions, lineage tracking and 
single cell transplantation studies are required to assess the ability of putative lung stem and 
progenitor cells in maintaining lung homeostasis and repair. 
 
Vast majority of human cancers carry mutations in p53, most commonly point mutations in one 
(p53mt/+) or both (p53mt/mt) p53 alleles (Lane, 1992; Lundin and Driscoll, 2012). These mutations 
result in expression of mutant p53 proteins that contribute to tumorigenesis either by inhibition 
of the wild type p53 activity or gain of function activities (Muller et al., 2011; Olive et al., 2004; 
Vaughan et al., 2012a). Mutation in p53 results in selective effects on the function of p53 protein 
thereby changing the phenotype of normal cells into cancerous nature. Advances in study of 
cancer stem cells (CSCs) across different tissues has allowed to identify putative cell surface 
markers that these cells express that contributes to distinguishing cancer stem cells from normal 
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cells (Klonisch et al., 2008). In our study, we investigated the expression of Sca-1 and PDGFR-α 
in lung population established from p53 mutants and p53+/+ wild type knock-in mice. The mice 
carrying point mutants p53R172H/+ and p53QSH/+, exhibited a ~ 3 fold increase in subpopulation of 
cells expressing Sca-1HighPDGFR-αHigh when compared with those isolated and propagated from 
p53+/+ wild type mice. Interestingly, Sca-1HighPDGFR-αLow subpopulation is higher in unsorted 
cells established from p53+/+ wild type mice and significantly lower in cells isolated from p53 
mutant mice. This shift in the subpopulations expressing putative stem cells markers, Sca-1 and 
PDGFR-α, indicates the potential effect of the p53 point mutations on the phenotype. Further 
characterization of Sca-1 and PDGFR-α expressing lung subpopulation in these cancer sensitized 
p53 mutants is thus required to establish PDGFR-α as a possible cancer stem cell marker.  
 
In summary, our results presented here suggest the importance of PDGFR-α as an important 
marker to sort out putative stem cells and progenitor cells from a heterogeneous lung tissue that 
comprises of multiple stem cell niches. Moreover, our results demonstrate an increase in Sca-
1High PDGFR-αHigh subpopulation in lungs isolated from cancer sensitized p53 mutants, 
indicating the potential use of PDGFR- α in sorting for subpopulations with defined stem cell 
characteristics and to further determining its importance in the context of lung cancer.
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CHAPTER 4:   CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
 
4.1 Conclusions 
4.1.1 Chapter 2 
Identifying somatic stem cells in various tissues has significantly progressed in the past decade, 
with use of specific cell surface markers to isolate resident stem cells that contribute to 
regeneration. Similar advancements in understanding lung biology have paved the way to 
identify and characterize lung stem/progenitor cells with multipotent differentiation potential. 
Unlike rapidly self-renewing tissues/organs like intestine, skin, and bone marrow, lung tissue 
does not exhibit high regenerative ability. However, identification and isolation of prospective 
lung stem/progenitor cells is of enormous interest given the increasing evidence of cancer stem 
cells in numerous tissue types. Given that lung cancer is the leading cause of cancer related 
mortality, identification and characterization of somatic lung stem cells not only aides in 
understanding the biology of the lung, but also in treating lung related disorders.  
In this study, we aimed to investigate the characteristics of Sca-1 expressing subpopulations 
isolated from cancer sensitized p53 mutant (p53R172H/+ & p53QSH/+) mice and compared with their
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 counterparts isolated from p53+/+ wild type mice. Based on different experimental outcomes, we 
arrived at the following conclusions: 
• Direct comparisons of phase contrast images demonstrate that the Sca-1High and Sca-1Low 
subpopulations from p53+/+ wild type comprise of a heterogeneous population. However, 
the same subpopulations isolated from cancer sensitized p53R172H/+ & p53QSH/+ mutant 
mice possess homogenous cells with prominent mesenchymal characteristics. 
• Cancer sensitized p53R172H/+ & p53QSH/+ mutant mice possess a significantly higher 
percentage of Sca-1High lung subpopulations, when compared with cell isolated from 
p53+/+ wild type mice. Comparisons within the two mutants indicate that the cells isolated 
from the p53R172H/+ knock-in mice possess a higher percentage of Sca-1High cells.  
• Cell lines isolated from p53R172H/+ & p53QSH/+ knock-in mice possess a higher colony 
forming ability at low seeding density and higher BMI-1 expression indicating their self-
renewal potential.  
• Cell lines generated from cancer sensitized p53 backgrounds exhibited a higher 
proliferation and self-renewal potential than those isolated from p53+/+ wild type mice. 
• Cell lines isolated from p53R172H/+ & p53QSH/+ knock-in mice demonstrated tumorigenic 
characteristics when compared to cell lines isolated from p53+/+ wild type mice as 
determined by:  
o Sca-1High and Sca-1Low subpopulations from p53R172H/+ background show a higher 
migration rate.  
o Sca-1High subpopulations from both p53R172H/+ & p53QSH/+ mutant backgrounds 
exhibited a significant colony formation in anchorage-independent growth 
conditions. 
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o Sca-1Low subpopulations from p53R172H/+ mice exhibited a significant colony 
formation in anchorage-independent growth conditions. However, Sca-1Low 
subpopulations from p53QSH/+ mice did not exhibit significant colony formation in 
anchorage-independent growth conditions. 
o Sca-1High and Sca-1Low subpopulations from p53QSH/+ mice express an 
accumulation of p53 protein, indicating that aberrant p53 protein is expressed in 
these cells. 
o Subpopulations from p53R172H/+ knock-in mice showed significant tumorigenic 
properties but did not show any p53 accumulation.    
•  Both Sca-1High and Sca-1Low subpopulations from the p53+/+ wild type mice exhibit 
differentiation potential when differentiated into osteogenic and adipogenic lineage, 
while Sca-1High subpopulations showed more homogenous differentiation ability 
compared to the Sca-1Low subpopulation. 
• Subpopulations isolated from cancer sensitized p53 mutants did not show any adipogenic 
differentiation. However, Sca-1Low subpopulation from mutant mice showed scarce 
osteogenic differentiation. 
• To further understand the potential role of p53 in regulating Sca-1 and PDGFR-α we 
performed Ingenuity pathway analysis, based on peer reviewed published interaction 
data. We observed that, p53 regulates the expression of Sca-1 and PDGFR-α, which 
probably, explains the increase in Sca-1and PDGFR-α expression in lung cell lines that 
carry p53 point mutations. Our analysis also shows a direct interaction between p53 and 
BMI-1 inside the nucleus (Figure 4-1). Based on the Ingenuity pathway interaction data, 
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it is reasonable to expect that point mutations in p53 resulted in increased expression of 
Sca-1, PDGFR-α  and BMI-1 genes.  
• Our current data supports low differentiation potential of lung sub-populations carrying 
p53 point mutations. Hence, we investigated if p53 regulates any genes that are involved 
in mesenchymal lineage differentiation. The process of adipocyte differentiation is tightly 
regulated by a number of transcription factors, hormones and signaling pathway 
molecules(Rosen and MacDougald, 2006). Adipogenesis from pre-adipocytes into mature 
adipocyte is precisely coordinated by transcription factors such as CCAAT-enhancer-
binding proteins (C/EBPs) and peroxisome proliferator-activated receptor γ (PPARγ), 
cytokines, and hormones(Wu et al., 1999). Based on ingenuity analysis, we noted that 
p53 inhibits the expression of PPARγ, an important transcription factor in adipogenesis. 
We hypothesize that as a result of p53 point mutations, cellular accumulation of p53 
could occur and inhibit PPARγ, thereby resulting in loss of cells during the differentiation 
process and lack of differentiation further (Figure 4-1). 
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Figure 4-1: Possible role of p53 in regulating expression of genes investigated in this study   
Using ingenuity pathway analysis, the role of p53 in regulating gene expression of Sca-1, 
PDGFR-α, BMI-1, and PPARG were analyzed. Known relationships based on ingenuity 
database are designated on line connectors. (A) Activation, (E) Expression, (I) Inhibition, (P) 
Phosphorylation, (PP) Protein-Protein interaction, (UB) Ubiquitination, (L) Molecular cleavage. 
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4.1.2 Chapter 3 
Our current understanding of resident lung stem cells is not comprehensive. The distinction 
between adult stem cells and progenitor cells is still an area of active research. The lung is a 
complex organ comprised of different types of cells with distinct functionalities and it is thus 
important to tease apart these differences both in vitro and in vivo. Various research studies have 
indicated the existence of mesenchymal and epithelial stem cells in the lung, but identifying cell 
surface markers that homogenously identify these populations is still a research question. Here, 
for the first time we have isolated and characterized lung cells differentially expressing two cell 
surface markers Sca-1 and PDGFR-α in p53+/+ wild type mice with the goal to identify and 
characterize a pure population of mesenchymal lung stem cells. We compared the characteristics 
of these subpopulations with those lung cells that were isolated based on Sca-1High and Sca-1Low 
only expression. Our results obtained from different experiments conducted in this study support 
the following conclusions: 
• Existence of different subpopulations in the lung that express Sca-1 and PDGFR-α. 
• Lung cells expressing Sca-1LowPDGFR-αHigh and Sca-1HighPDGFR-αHigh 
subpopulations constitute cells with higher proliferation capabilities.  
• Sca-1LowPDGFR-αHigh subpopulation exhibit a higher BMI-1 expression and a higher 
N-cadherin expression, indicating their proliferating and mesenchymal nature.  
• Sca-1LowPDGFR-αHigh subpopulation lack adipogenic and osteogenic differentiation 
potential.  
• Even though all other subpopulations show adipogenic and osteogenic differentiation 
potential, Sca-1HighPDGFR-αLow and Sca-1HighPDGFR-αHigh subpopulations exhibit 
more robust differentiation capabilities. 
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• Increase in Sca-1HighPDGFR-αHigh subpopulation in lungs isolated from cancer 
sensitized p53 mutants. 
• Based on our preliminary results, PDGFR-α is a potential marker in sorting for 
subpopulations with defined stem cell characteristics.  
 
4.2 Future directions 
4.2.1 Chapter 2 
Our results suggest that subpopulations isolated and propagated from cancer-sensitized p53 
mutants show distinct tumorigenic properties such as a high migration rate, high proliferation, 
and colony formation in non-adherent culture conditions. Our preliminary results suggests that 
these cells show limited mesenchymal differentiation potential compared to those cells derived 
from wild type mice. We propose to further test the differentiation potential of these cells into 
different lung lineages and hypothesize that Sca-1High cells from p53 mutant mice possess 
unipotent rather than multipotent differentiation potential. Based on the outcome of this studies, 
we will also test the ability of Sca-1High cancer-sensitized cells to induce tumor formation in 
immune compromised mice. This could be achieved by the following specific aims:  
Specific aim 1: Characterize Sca-1 expressing lung cells from p53 mutant mice for their 
differentiation ability to other lung lineages.  
The goal of this specific aim is to characterize and compare the lineage specific differentiation 
capability of Sca-1 expressing lung cells. We will first investigate the expression of lung lineage 
specific genes in the sorted lungs by Q-PCR and immuno-staining. Based on these results, we 
will further subject the subpopulations to differentiation medium for lung endothelial and 
epithelial cell types, specifically into alveolar type I, II, and clara cells. We will compare and 
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quantitate the differentiation capability and assess the self-renewal ability by assaying lineage-
specific marker expression with Q-PCR and Western blot analysis. We expect that results from 
this specific aim will assist in further evaluating the stem cell characteristics of specific 
subpopulations from cancer sensitized mice.  
Specific aim 2: Determining the tumor-propagating ability of Sca-1 sorted cells across cancer-
sensitized p53 mutant genotypes. 
The goal of this specific aim is to establish the cancerous nature of putative lung stem cells in 
vivo. For this purpose, we will first investigate the expression of known cancer stem cell markers 
in these subpopulations by flow cytometry and conduct gene expression studies by Q-PCR. We 
will further transplant these Sca-1 expressing cells into NOD/SCID immune-deficient mice to 
investigate their proliferation and self-renewal nature in vivo by lineage labelling strategy. We 
expect that Sca-1 cells isolated from the p53 mutant mice will form a tumor and metastasize.  
  
4.2.2 Chapter 3 
The two-marker strategy to identify lung stem cells in this study supports the existence of Sca-
1Low PDGFR-αHigh subpopulation with no differentiation capability. Our preliminary results 
points to the potential role of PDGFR-α as a stem cell marker in the lung. We propose to test the 
significant role of PDGFR-α expressing cells by characterizing the sorted cells for their ability to 
differentiate into various lung lineages. We will further characterize the ability of these 
subpopulations to maintain long-term self-renewal and assess their role in lung repair. We 
speculate that results from the following specific aims will assist in enhancing our knowledge of 
lung biology, by delineating long-term self-renewing lung stem cells from the short term self-
renewing progenitor cells. 
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Specific aim 1: To evaluate long-term self-renewal potential of putative lung stem cells 
identified by PDGFR-α and Sca-1 expression 
It is important to understand the long-term self-renewal nature of lung cells differentially 
expressing Sca-1 and PDGFR-α. For this purpose, we will test the differentiation potential of 
these subpopulations over a time period of early and late passages. To ascertain both self-
renewal and differentiation potential of these cells, we will select colonies obtained from a single 
cell and induce differentiation. We will test the long-term differentiation potential of these cells 
into clara cells (epithelial), adipocytes (mesenchymal), and bronchiolar (endothelial) lineages 
across early and late passages. We will further quantitate the expression of respective lineage 
markers at the end of the differentiation period. The results from this specific aim will help to 
distinguish differences in long-term self-renewal potential of these subpopulations, which will 
shed some light on uni- and multi-potent differentiation capabilities of these subpopulations. 
  
Specific aim 2: To evaluate the regeneration ability of the Sca-1 and PDGFR-α cells in mice 
models of lung injury 
In order to identify the role of Sca-1 and PDGFR-α expressing lung subpopulation in turnover 
and repair after injury, we propose to study mouse models of lung injury (naphthalene) that 
specifically depletes clara cell population. This will be achieved by a lineage labelling strategy 
that can track the subpopulations in vivo. The results from these in vitro and in vivo studies that 
investigate the regeneration potential of sorted subpopulations will aide us in better 
understanding the putative lung stem cell populations expressing Sca-1 and PDGFR-α. 
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APPENDIX 
 
Appendix i: Conjugated antibodies list 
Antibody Sca-1-FITC 
FITC 
Isotype 
Ctrl 
PDGFR-α 
-APC 
APC-
Isotype 
Ctrl 
CD 31-
PE 
CD-
45RA-
PE 
Company Bio-legend BD Pharmigen 
Catalog # 108105 400505 135907 135907 561073 551402 
Stock Conc.( µg) 50 50  25  25  25 100 
Total volume 
(µl) 100  100  125  125 125 500 
Stock 
Conc.(mg/ml) 0.5  0.5  0.2  0.2  0.2  0.2 
Working Conc. 
 
1 µg per Million cells in 100 µl volume 
 
Volume required 
from stock 2 µl 2 µl 5 µl 5 µl 5 µl 5 µl 
 
 
Appendix ii: Cell Counting with BD Accuri ™ C6 
 
1. Trypsin passage cells at confluence 
2. Centrifuge and discard the trypsin medium. Re-suspend the pellet in 1 ml of fresh growth 
medium.
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3. Aliquot 100 µl of the cell suspension into 0.5 ml centrifuge tubes and run through BD 
Accuri™ C6 flow cytometer. 
4. Flow run settings: Run 50 µl of respective sample, at a 
Medium fluidics speed. Plot FSC-Area vs SSC-Area (as 
in example image) to gate the healthy cell population. 
Note the number of events in the healthy gate.  
5. Divide the number events by volume run on flow (Ex: 
10000 events/50 µl i.e. 200 events/ cells per µl) to obtain events or cell number per µl. 
Extrapolate to the total volume the cells are suspended in to get the total cell number. 
(900 µl * 200 = 180,000 cells) 
6. Prepare a working cell suspension of 50,000 cells per 1 ml. (Ex: 250 µl of cell suspension 
in 750 µl of fresh growth medium. 
7. Add required number of cells for respective experiment.  
8. NOTE:  For larger pellets increase the re-suspension volume to avoid clumping. 
9. Triturate the cell suspension repeatedly before running through the flow cytometer. 
Avoid bubbles. 
 
 
Appendix iii: Differentiation and staining protocol 
 
Adipogenic differentiation medium: DMEM High Glucose 1x (Gibco Cat# 11965-092), 10% 
FBS (Hyclone Cat# SH30070.03), 1x Penicillin/Streptomycin (Life Technologies Cat# 15140-
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122), 1:50,000 dilution of 1mM insulin (Sigma Cat#I2643) and 1:10,000 dilution of 10 µM T3 
(Sigma Cat# T-2877). 
Adipogenic induction medium: To the complete adipogenic differentiation medium, add 0.125M 
Indomethacin ( Sigma Cat# I-7378), 2mg/ml dexamethasone (Sigma cat# D2915), 0.25M IBMX 
( Sigma Cat# I-5879) along with 1mM insulin ( Sigma Cat#I2643) and 10 µM T3 ( Sigma Cat# 
T-2877). (Prepare it fresh for every use). Note: For proper dissolution indomethacin and IBMX 
should be heated to 75 C before adding to medium. 
Osteogenic differentiation medium: MEM 1x (Gibco Cat# 11090-081), 10% FBS (Hyclone Cat# 
SH30070.03), 1x Penicillin/Streptomycin (Life Technologies Cat# 15140-122),  L-Glutamine ( 
Gibco Cat# 25030081) with 10nM Dexamethasone (Sigma Cat# D2915), 50 µM L-Ascorbic acid 
2-phosphate (Sigma Cat# A8960) and 20mM ß-Glycerophosphate disodium salt hydrate (Sigma 
Cat# G9422). 
Oil Red O Stain: To prepare stock solution, dissolve 0.5 g of Oil Red O powder (Santa Cruz 
Biotech, Cat# SC-203749) in 100 ml of isopropanol. The solution can be stored up to 3 months. 
For working solution, dilute 3 ml of stock solution in 2 ml of de-ionized water and filter it 
through Whatman Grade 1 filter paper. Prepare working solution fresh as per need. 
Alizarin Red S Stain: Dissolve 1.369 g of Alizarin Red S ( Santa Cruz Biotech, Cat# 205998) in 
100 ml of distilled water. After complete dissolution the pH should be around 4.2. If not, adjust 
the pH using Ammonium hydroxide. The solution could be stored up to 3 months.  
Adipogenic differentiation and staining  
Day 1: Plate cells on a tissue culture plate at 5000 cells per cm2 in adipogenic differentiation 
medium.  
Day 2: Allow cells to grow 100 % confluence. 
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Day 3: Allow cells to grow 100 % confluence. 
Day 4: If the cells are 100 % confluent, then aspirate the medium and replace fresh adipogenic 
induction medium. 
Day 5: Do not disturb the cells. 
Day 6: Gently replace the induction medium with adipogenic differentiation medium. 
Day 7: Do not disturb the cells. 
Day 8: Gently replace medium with fresh Adipogenic differentiation medium. 
Day 9: Do not disturb the cells. 
Day 10: Visible oil droplets should be noted at this point. Capture bright field images of the oil 
droplets. 
NOTE: As the adipogenic differentiation progress the cells tend to detach from the surface. 
Hence, be gentle in movement, medium changes and washes.  
Oil Red O Staining: Replace growth medium and wash the cells with PBS++ 
1. Fix the cells with 10% (v/v) formaldehyde (Sigma Cat# F8775) prepared in PBS++ and 
incubate at room temperature for 20 minutes.  
2. Replace the fixative agent with freshly prepared Oil Red O working solution. Make sure 
the working solution is filtered properly. Incubate at room temperature for 1 hr. 
3. Rinse the plates 2 to 3 times with di H20 to remove excess stain or precipitate.  
4. Dry the plates. Visualize and capture images of the stained monolayers. 
Osteogenic differentiation and staining  
1. Plate cells on a tissue culture plate at 2500 cells per cm2 in MLSC growth medium. 
2. Allow cells to grow 70 % confluence. 
3. Replace the medium with osteogenic differentiation medium. 
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4. Allow the cells to propagate for 14-21 days with medium replacement on every alternate 
day. 
5. Monitor the cells for calcification mineral deposition. Capture images using an inverted 
microscope.  
Membrane Alkaline Phosphatase (AP) staining: After 7 days in osteogenic differentiation 
medium the cells can be tested for expression of membrane alkaline phosphatase. For this 
purpose, wash the cells with PBS++, fix them in 4% (w/v) PFA for 10 minutes and appropriate 
volume of BCIP/NPT staining solution (Sigma B3804) is added. The plates are covered and 
incubated for 20-30 minutes at room temperature. Visible blue (low AP expression) to dark 
purple (high AP expression) color staining is observed at the end of incubation. 
Alizarin Red S (ARS) Stain:  After the 14 days of differentiation period 
1. Wash the cells in di H20.   
2. Fix the cells in 10% (v/v) formaldehyde (Sigma Cat# F8775) prepared in di H20. 
3. Wash twice in di H20, add appropriate volume of ARS stain and incubate the plates at 
room temperature for 1 hour. 
4. Wash the plates 2-3 times with di H20 until the stain precipitate is aspirated out. 
5. Visualize and capture images of the stained monolayers. 
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Appendix iv: Primer list 
Gene ID Gene Name Direction Sequence GC % Product length 
12250 Mouse-E-cadherin 
Forward caggtctcctcatggctttgc 57.1 175 Reverse cttccgaaaagaaggctgtcc 52.4 
12258 Mouse N-cadherin 
Forward atagcccggtttcacttgaga 47.6 160 Reverse caggctttgatccctctgga 55 
12151 Mouse BMI-1 Forward cttgctggtctccaagtaacg 52.4 118 Reverse aaatccccacttaatgtgtgtcc 43.5 
14433 Mouse GAPDH Forward aggtcggtgtgaacggatttg 52.4 95 Reverse ggggtcgttgatggcaaca 57.9 
71950 Mouse-Nanog Forward cacagtttgcctagttctgagg 50 87 Reverse gcaagaatagttctcgggatgaa 43.5 
110454 Mouse Sca-1 Forward gaggcagcagttattgtggat 47.6 112 Reverse cgttgaccttagtacccagga 52.4 
18595 Mouse PDGFR-α Forward atgagagtgagatcgaaggca 47.6 130 Reverse cggcaaggtatgatggcagag 57.1 
648 Human BMI-1 Forward ccacctgatgtgtgtgctttg 52.4 162 Reverse ttcagtagtggtctggtcttgt 45.5 
5460 Human-Oct4 Forward gggagattgataactggtgtgtt 43.5 144 Reverse gtgtatatcccagggtgatcctc 52.2 
2597 Human-GAPDH Forward ttgccatcaatgaccccttca 47.6 174 Reverse cgccccacttgattttgga 52.6 
 
 
Appendix v: RNA extraction, cDNA and Q-PCR reaction setup 
 
RNA/ DNA Extraction 
1. Plate 5000 cells per cm2 in 60 mm dish and propagate until confluence. 
2. Collect the cells in trypsin, quench trypsin action in growth medium and wash the cells 
with PBS++. 
3. Pellet the cells by centrifuging at 1000 rpm for 4 minutes and aspirate PBS++, without 
disturbing the pellet.  
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4. Snap freeze the pelleted cells in liquid nitrogen for 10 seconds. The cells could be stored 
at -80 c until ready for RNA extraction.  
5. Extract RNA and DNA using the AllPrep DNA/RNA Mini Kit (Qiagen Cat# 80204). 
6. After extraction measure the quantity of RNA and DNA using nano drop 2000.  
7. Dilute RNA to 100 ng/µl and proceed to cDNA synthesis step 
8. Dilute DNA to 10 ng/ul and proceed to Genotyping step. 
 
cDNA synthesis reaction setup 
PCR Reaction 
Setup 
Stock 
Conc. 
per 20 
µl Rxn 
Final 
Conc. 
10x RT Buffer 10 2 1 
25x dNTP Mix 
100mM 100 0.8 4 
10xRT Random 
Primer 10 2 1 
Reverse 
Transcriptase 10 1 0.5 
Nuclease Free H20  4.2  
100 ng/ul RNA 100 10 50 
Total volume  20  
 
Cycling Step Temperature & Time 
Incubation 10 min at 25 
RT reaction 
120 min at 37 
C 
Enzyme 
Inactivation 5 min at 85 
Storage End at 4 C 
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Q-PCR reaction setup 
PCR Reaction 
Setup 
 Stock 
Conc. 
per 25 
µl Rxn  
Final 
Conc. 
2x SybrGreen Mix 2 12.5 1 
dd H20   5.5   
Total volume   18   
5uM Forward 
primer 5 1 0.2 
5uM Reverse 
primer 5 1 0.2 
1 ng/µl cDNA 1 5 0.2 
Total volume   7   
 
 
Cycling Step Temperature & Time Cycles 
Polymerase 
Activation 
10 min at 95 
C   
Denaturation 15 sec at 95 C 40 
Cycles Annealing/Extension 30 sec at 58.5 
 
 
Standard PCR reaction setup 
PCR Reaction 
Setup 
 Stock 
Conc. 
per 20 
µl Rxn  
Final 
Conc. 
10x PCR buffer 10 2 1 
10uM Forward 
primer 10 0.4 0.2 
10uM Reverse 
primer 10 0.4 0.2 
500 Units Taq Pol 500 0.4 10 
dd H20   13.8   
50 ng/µl DNA  50 3 7.5 
Total volume   20   
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Cycling Step Temperature & Time Cycles 
Initial denaturation 
10 min at 95 
C 1 
Denaturation 30 sec at 95 C 
34 
Cycles Annealing 30 sec at 56.5 
Extension 45 sec at 72 C 
Final Extension 4 min at 72 C 1 
 
Agarose gel preparation 
• Dissolve 2g of ultra-pure agarose in 100 ml of TAE buffer. Heat until agarose dissolves 
into solution. Let it cool to about 50 C 
• Add 6 µl of ethidium bromide carefully and stir under the exhaust hood. Pour the solution 
into a gel tray and let it cool. Once gel is formed, carefully pull the comb without 
breaking the gel. 
• Mix 20 µl of PCR end-product with 4 µl loading dye and add it to wells. Load 
appropriate gel ladder in one well. Run the gel at 100 V for about 1 -2 hours.  
• Capture images of the bands under a gel dock reader.  
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Appendix vi: BCIP-AP staining in negative control 
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Appendix vii: Migration assay on Sca-1High and Sca-1Low subpopulations across different 
p53 backgrounds 
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Appendix viii Immunoblotting (Western Blot) 
1. Sample preparation 
• Cells must be confluent and ready to be harvested from a 60mm cell culture plate. 
• Use the total protein extraction kit which has 50x Protease inhibitor cocktail + TM lysis 
buffer (with NP40). Make 1x Protease inhibitor by diluting it from 50x using lysis buffer. 
 
• Wash the cell plate with PBS after aspirating the media out. Be careful not to leave any 
traces of media in the plate as this will obstruct viewing the protein of interest on SDS 
PAGE later on. 
• Use ice cold PBS and cold tubes for the rest of the sample preparation. 
• Trypsinize the cells and spin them down. 
• Wash the cell pellet with PBS. 
• Add 100 μl of lysis buffer to 1 million cells. 
• Pipette it up and down. 
• Tape the tubes down to a vortex and keep it on constant agitation at 4°C for 30 minutes. 
• Centrifuge at 13000 g at 4°C for 15-20 minutes. 
• Collect the supernatant and dump the pellet. The supernatant is the protein. 
2. Protein concentration: BSA assay 
• Dye reagent (5x) 
• BSA lyophilized powder 
• Add 20 ml water to do the BSA powder and mix it to get a 1.44 mg/ml protein solution. 
• Make three dilutions of protein solution (0.2 mg/ml, 0.4 mg/ml, 0.8 mg/ml). 
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• 0.8 mg/ml: 1.44 mg – 1ml 
• 0.8 mg – 0.8/1.44 = 0.556 ml 
• Add 0.444 ml dd H2O 
• 109 
• 1ml of 0.8 mg/ml solution 
• 0.4 mg/ml: Take 0.5 ml of 0.8 mg/ml and add 0.5 ml of dd H2O to get 1 ml of 0.4 mg/ml 
solution. 
• 0.2 mg/ml: Make 1ml of protein solution in the same way as above. 
• Dye reagent: 1 part of 5x dye + 4 parts water = 25 ml dye (1x) 
• Pour the dye reagent through a Whatman filter paper. 
• Take 20 μl of protein (standards/sample) for 1ml of dye reagent and vortex it properly 
and incubate it for 5min at room temperature. 
• Perform spectrophotometric analysis at 595nm to get the OD values. 
• Only 30 μg of protein per well in gel. Do the calculations and take the required amount of 
protein sample and make up the volume to 30 μl using laemmli buffer (1:1 or 1:2). 
• Before using the laemmli buffer, it is required to add β-mercaptoethanol to the laemmli 
buffer. 
• Add 50 μl β-mercaptoethanol to 950 μl Laemmli buffer and mix it well. 
• Add 1:1 ratio of Laemmli buffer to protein sample. 
• Boil water on a burner, parafilm-seal the lids of the eppendorf tubes that contain sample 
and place the samples in boiling water for around 10 minutes. 
• Spin them down to the bottom of the tube. 
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3. Running SDS PAGE 
• Making running buffer: Take 900ml ddH2O in a glass bottle and add 100ml of Tris-
Glycine-SDS and mix it well. 
• Once the samples and buffers are ready, take them near the running apparatus. 
• Get the gel ready from 4°C and take the tape off the bottom of the gel. 
• Place it carefully in the gel holder and make sure to place the gel in a way that the wells 
are facing inside. Balance the other side using another gel if you are running two gels at 
the same time or use a dam to seal the other end. 
• Pour running buffer into the gel holder to check if it is sealed well. 
• Once it is established that there are no leaks, go ahead and take the comb out of the wells 
and saturate it with running buffer. 
• Load ladder and samples carefully into the respective wells without releasing air bubbles 
into the well from the pipette. 
• Run at 20mA for around 45min or till the protein reaches the bottom of the gel. Be 
careful not to let the protein run out from the bottom of the gel. If the gel has run well, the 
ladder is well separated. 
4. Transfer onto nitrocellulose membrane 
• Preparation: While the SDS PAGE is still running, get the transfer buffer ready and store 
it at 4°C. 
• Take 700 ml water, 100 ml tris-glycine, 200 ml methanol and mix it well. 
• Take ice in white ice-holder and fill it with a little water and keep it at -20°C until use. 
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• Cut the required size of the nitrocellulose and be careful not to touch without gloves and 
hold it using forceps. Place it in some transfer buffer. 
 
• Wet the sponges and filter paper in the transfer buffer as well. 
• Once the gel is run, carefully break open the gel case without breaking the gel. 
• Place the nitrocellulose on gel supported by a filter paper. 
• Let the gel come onto the membrane and then place another filter paper on gel. 
• Press them smoothly and now place sponges on either side and roll a Pasteur pipette on 
this sandwich tightly to get rid of bubbles. (IMPORTANT) 
• Do not forget the gel side and the membrane side. 
• Black side: Gel 
• Clear side: Nitrocellulose membrane 
• Clear side should go next to red and black side onto black and back goes back. Place the 
other sandwich with another set of gel-membrane or plain sponges. 
• Place the ice pack in the apparatus and place the whole apparatus in a trough containing 
ice. 
• Now pour the cold transfer buffer into the apparatus and run it at 90V for around 1 hour 
15 min-30min. 
• You know the transfer has begun once you notice bubbles rising up from the bottom. 
• The transfer is successful when the ladder is perfectly visible on the nitrocellulose 
membrane. 
5. Blocking and washes: 
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• Use 3% block solution or make 5% block using nonfat casein powder in TBS-Tween 
solution 
• TBS-Tween: 900ml water, 100ml TBS, 1ml Tween-20 
• Do a 10 min wash with TBS-Tween. 
• Primary and Secondary Antibodies: 
• Make the primary antibody solution in 0.1% TBS-Tween solution (15ml). It can be 
reused when stored at 4°C. 
• Add it to the washed membrane and leave it overnight at 4°C with constant agitation or 
upto 2 hrs. at room temperature with stirring. 
• Do 3x 10 min washes with TBS-Tween. 
• Make secondary antibody in TBS-Tween (10ml). 
• Add it onto membrane and leave it on stirring for 1 hour. 
• Do not reuse the secondary antibody solution. Do 3x 10 min washes with TBS-Tween 
and detect using the Odyssey Infrared Imaging System (Li-Cor Biosciences, NE).
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